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A B S T R A C T
Background
There are 76.3 million people with alcohol use disorders worldwide and 15.3 million with drug use disorders. Motivational interviewing
(MI) is a client-centred, semi-directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence.
The intervention is used widely, and therefore it is important to find out whether it helps, harms or is ineffective.
Objectives
To assess the effectiveness of motivational interviewing for substance abuse on drug use, retention in treatment, readiness to change,
and number of repeat convictions.
Search strategy
We searched 18 electronic databases, 5 web sites, 4 mailing lists, and reference lists from included studies and reviews. Search dates
were November 30, 2010 for Cochrane Library, Medline, Embase and PsychINFO.
Selection criteria
Randomized controlled trials with persons dependent or abusing substance. Interventions were MI or motivational enhancement
therapy. The outcomes were extent of substance abuse, retention in treatment, motivation for change, repeat conviction.
Data collection and analysis
Three authors independently assessed studies for inclusion, and two authors extracted data. Results were categorized into (1) MI versus
no-treatment control, (2)MI versus treatment as usual, (3)MI versus assessment and feedback, and (4)MI versus other active treatment.
Within each category, we computed meta-analyses separately for post-intervention, short, medium and long follow-ups.
Main results
We included 59 studies with a total of 13,342 participants. Compared to no treatment control MI showed a significant effect on
substance use which was strongest at post-intervention SMD 0.79, (95% CI 0.48 to 1.09) and weaker at short SMD 0.17 (95% CI
0.09 to 0.26], and medium follow-up SMD 0.15 (95% CI 0.04 to 0.25]). For long follow-up, the effect was not significant SMD 0.06
(95% CI-0.16 to 0.28). There were no significant differences betweenMI and treatment as usual for either follow-up post-intervention,
short and medium follow up. MI did better than assessment and feedback for medium follow-up SMD 0.38 (95% CI 0.10 to 0.66).
For short follow-up, there was no significant effect . For other active intervention there were no significant effects for either follow-up.
There was not enough data to conclude about effects of MI on the secondary outcomes.
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Authors’ conclusions
MI can reduce the extent of substance abuse compared to no intervention. The evidence is mostly of low quality, so further research is
very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
P L A I N L A N G U A G E S U M M A R Y
Motivational interviewing is a short psychological treatment that can help people cut down on drugs and alcohol
More than 76 million people worldwide have alcohol problems, and another 15 million have drug problems. Motivational interviewing
(MI) is a psychological treatment that aims to help people cut down or stop using drugs and alcohol. The drug abuser and counsellor
typically meet between one and four times for about one hour each time. The counsellor expresses that he or she understands how the
clients feel about their problem and supports the clients in making their own decisions. He or she does not try to convince the client to
change anything, but discusses with the client possible consequences of changing or staying the same. Finally, they discuss the clients’
goals and where they are today relative to these goals. We searched for studies that had included people with alcohol or drug problems
and that had divided them by chance into MI or a control group that either received nothing or some other treatment. We included
only studies that had checked video or sound recordings of the therapies in order to be certain that what was given really was MI. The
results in this review are based on 59 studies. The results show that people who have received MI have reduced their use of substances
more than people who have not received any treatment. However, it seems that other active treatments, treatment as usual and being
assessed and receiving feedback can be as effective as motivational interviewing. There was not enough data to conclude about the
effects of MI on retention in treatment, readiness to change, or repeat convictions.The quality of the research forces us to be careful
about our conclusions, and new research may change them.
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B A C K G R O U N D
Description of the condition
According to theWorld Health Organization (WHO 2009) there
are 76.3 million people with alcohol use disorders worldwide. In
addition, there are at least 15.3 million people who suffer from
a drug use disorder, and injecting drug use is reported in 136
countries.
Substance abuse refers to the overindulgence in and dependence
on a drug or other substance leading to effects that are detrimen-
tal to the individual’s physical and mental health, or the welfare
of others. The disorder is characterized by a pattern of contin-
ued pathological use of a drug or other substance, that results
in repeated adverse social consequences related to drug use, such
as failure to meet work, family, or school obligations, interper-
sonal conflicts, or legal problems. There are on-going debates as
to the exact distinctions between substance abuse and substance
dependence. We follow the definitions by the American Psychi-
atric Association (APA 2000) and distinguish between the two by
defining substance dependence as a cluster of cognitive, behav-
ioral, and physiological symptoms indicating that the individual
continues use of the substance despite significant substance-related
problems. There is a pattern of repeated self-administration that
can result in tolerance, withdrawal, and compulsive drug-taking
behavior (APA 2000). Substance abuse is a maladaptive pattern
of substance use manifested by recurrent and significant adverse
consequences related to the repeated use of substances. In order
for an Abuse criterion to be met, the substance-related problem
must have occurred repeatedly during the same 12-month period
or been persistent.
Substance abuse may lead to addiction or substance dependence.
Medically, physiologic dependence requires the development of
tolerance leading towithdrawal symptoms. Both abuse and depen-
dence are distinct from addiction which involves a compulsion to
continue using the substance despite the negative consequences,
and may or may not involve chemical dependency (APA 2000).
Dependence almost always implies abuse, but abuse frequently
occurs without dependence, particularly when an individual first
begins to abuse a substance. There is also a distinction between
“misuse” and “abuse” of substances. Substance misuse is the in-
correct use of medication by patients, who may use a drug for
a purpose other than that for which it was prescribed; or use of
a substance for unintended purposes (APA 2000). The focus of
this review is substance abuse, dependency or addiction, but not
misuse.
Description of the intervention
Motivational interviewing (MI) was started by Miller (Miller
1983) and developed by Miller and Rollnick (Miller 1991). MI
is a client-centred, semi-directive method for enhancing intrin-
sic motivation to change by exploring and resolving ambivalence.
MI integrates the relationship-building principles of Carl Rogers
(Rogers 1951) with more active cognitive-behavioural strategies.
The intervention has four basic principles (described below). A
brief variant of MI is called Motivational Enhancement Ther-
apy (MET). MET is manual-based, and was developed as part
of Project MATCH (Project MATCH 1997). Project MATCH
was a large multi site trial comparing MI with cognitive behav-
ioral therapy (CBT) and twelve-step facilitation therapy.MI coun-
selling does not require professional training as nurse, psycholo-
gist, etc. Hence, MI may be incorporated in programmes run by
health care staff as well as e.g. prison staff. There are explicit stan-
dards for practitioners regarding education and competence, and
there is quality control to ensure that the method is in fact used
as intended. One instrument for assessing treatment integrity is
the Motivational Interviewing Treatment Integrity (MITI) scale
(Moyers 2005). For a description of various measures of treatment
fidelity in MI, we recommend the review by Madson and Camp-
bell (Madson 2006). Promising results have been reported as to
the effect of the method for alcohol dependence, smoking cessa-
tion, drug addiction, HIV-risk behaviours, treatment adherence,
diet & exercise, and eating disorders (Carey 2007; Burke 2004 ;
Hettema 2005; Rubak 2005). MI has recently been introduced
into the criminal justice system, in Europe as well as in North-
America. In the research literature, the most widely used approach
related to MI has been one in which the client is given feedback
based on individual results from standardized assessment measures
or a modification of it. Burke et al. (Burke 2003) considered this
feedback-based approach to constitute an adaptation of motiva-
tional interviewing (AMI) because it is defined by the presence of
the feedback component and not solely by the use of motivational
interviewing per se. More broadly, they also applied the term AMI
to interventions that incorporate additional non-motivational in-
terviewing techniques while retaining motivational interviewing
principles as the core of treatment as well as to interventions that
have been specifically adapted for use by non-specialists.
How the intervention might work
MI is intended to work through its four main principles: (1) ex-
press empathy, (2) support self-efficacy, (3) roll with resistance,
and (4) develop discrepancy. As expressed on the official homepage
of Motivational Interviewing (http://motivationalinterview.org/
clinical/principles.html), expressing empathy involves seeing the
world through the client’s eyes. Supporting self-efficacymeans that
clients are held responsible for choosing and carrying out actions
to change. The third principle, rolling with resistance, means that
the counsellor does not fight client resistance, but “rolls with it.”
Statements demonstrating resistance are not challenged. Instead
the counsellor uses the client’s “momentum” to further explore the
client’s views. Lastly, motivation for change occurs when people
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perceive a discrepancy betweenwhere they are andwhere theywant
to be. MI counsellors work to develop this situation through help-
ing clients examine the discrepancies between their current behav-
ior and future goals. When clients perceive that their current be-
haviours are not leading toward some important future goal, they
become more motivated to make important life changes. Apodaca
and Longabaugh (Apodaca 2009) did a literature search to identify
potential within-session mechanisms of change in MI. The most
consistent evidence was found for three constructs: client change
talk/intention (related to better outcomes); client experience of
discrepancy (related to better outcomes); and therapist MI-incon-
sistent behavior (related to worse outcomes).
Why it is important to do this review
The intervention is used widely, and therefore it is important to
find out whether it helps, harms or is ineffective. Several reviews
and meta-analyses have been published (e.g. Andreasson 2003;
Burke 2003; Burke 2004; Carey 2007; deWildt 2002; Dunn
2001; Emmelkamp 2006; Grenard 2006; Hettema 2005; Larimer
2007; Lundahl 2010; Nahom 2005; Rubak 2005; Vasilaki 2006
) but they all differ somewhat from our review. Some of them
have studied effects of MI (AMI) on other groups in addition to
substance abusers or studied only alcohol abusers. Others included
other designs in addition to randomised trials. The main strengths
of the present review are that it employs a comprehensive and
systematic search strategy aiming to be exhaustive, and that it
includes only randomized controlled trials. We will also assess the
risk of bias of the included studies and grade the evidence for the
primary outcomes.
O B J E C T I V E S
To assess the effectiveness of motivational interviewing, as a pri-
mary or support intervention, for substance abuse, in terms of lev-
els of drug use, retention in treatment, and readiness for change.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included studies where units (persons, therapists, institutions)
were allocated randomly or quasi-randomly to motivational inter-
viewing or other conditions. Included studied had to be published
in or after 1983, which was the year that MI was introduced. We
had no limitation on length of study. We excluded studies that re-
cruited participants in emergency rooms and provided one session
of MI during the stay in the emergency room.
Types of participants
Persons defined as having either substance abuse, dependency or
addiction, but not misuse. There were no limitations on age or
other participant characteristics. The term substance refers to a
drug of abuse, a medication, a toxin or alcohol, excluding nico-
tine. The reason for excluding nicotine, is that there is an exist-
ing Cochrane review on motivational interviewing for smoking
cessation (Lai 2010). According to International classification of
Diseases version 10 (ICD-10) (WHO 1993) we included the fol-
lowing codes, F10 to F19*, excluding F15 (caffeine) and F17 (to-
bacco). Equivalent disorders and codes in the Diagnostic and Sta-
tistical Manual of Mental Disorders, third revised edition (DSM-
III-R) (APA 1987) and fourth edition, (DSM-IV) (APA 1994),
chapter Substance-Related disorders, were also included. We also
included studies in which substance abuse was not formally diag-
nosed. Participants could be dual diagnosis clients. We included
both participants who only abuse substances and participants who
also have mental problems, but we analysed the two groups sepa-
rately.
*[Mental and behavioural disorders due to use of - alcohol (F10
- 303), - opioids (F11), - cannabinoids (F12), - sedatives or hyp-
notics (F13), - cocaine (F14), - other stimulants (amphetamine)
(F15), - hallucinogens (F16), - volatile solvents (F18) and - mul-
tiple drug use and use of other psychoactive substances (F19).]
Types of interventions
Experimental intervention
Primarily, the interventions should be labelled motivational inter-
viewing (M)) or motivational enhancement therapy (MET). The
intervention could basically be offered in three ways: (1) as a stand-
alone therapy, (2) MI integrated with another therapy, or (3) MI
as a prelude to another therapy (e.g. cognitive behavioral therapy).
Only individual, face-to-face interventions were included. We ex-
cluded group interventions, and interventions not given in per-
son (e.g. computer-delivered or telephone interventions). Because
most psychosocial interventions have many unspecific elements in
common, and because terms like “motivational intervention” and
“motivational interview” not necessarily refers to Miller’s specific
program of MI, we included only studies that reviewed audio or
video recordings to ensure that the intervention given was indeed
MI.
Studies had to include checks of audio- or videotaping of sessions
in order to assess fidelity of treatment.
Control intervention
The comparator could be no intervention, waiting list control,
placebo psychotherapy or other active therapy.
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Types of outcome measures
Data on substance abuse could be both dichotomous (number of
participants ceasing substance abuse) and continuous (e.g. mean
number of days used in last 30 days). Substance abuse could also be
measured using various scales or inventories like the OTI (Opiate
Treatment Index) (Darke 1991; Darke 1992), the Timeline Fol-
low-Back (Sobell 1992), and the Rutgers Alcohol Problems Index
(RAPI; White 1989).
Primary outcomes
• cease of substance use measured by self-report, report by
collaterals, urine analysis, or blood samples, etc.
• reduction in substance abuse measured as above.
Outcomes are typically recorded as a posttest immediately after
the interventions ended, short-term follow-ups until six months
after the intervention ended, medium-term follow-ups of between
six and 12 months, and long-term follow-ups of 12 months or
longer. The exact follow-up durations are recorded for each study.
Secondary outcomes
• Retention in treatment.
• Improve motivation for change, e.g. measured by the
Readiness to Change Questionnaire (RCQ; Heather 1993).
• Number of repeat convictions (for convicted substance
abusers).
Search methods for identification of studies
Electronic searches
We searched the following electronic databases: Medline (1950
to November Week 3, 2010), Embase (1980 to 2010, week 4),
PsycInfo (1806 to November week 4, 2010), PsychExtra (1908 to
January 14, 2008), Cochrane Central Register of Controlled Tri-
als (search date: November 30, 2010), C2-SPECTR (Search date:
November 23, 2009), International Bibliography of the Social Sci-
ences (1951 to November week 3, 2009), Sociological Abstracts
(search date: November 30, 2010), ISI Web of Science (search
date: November 30, 2010), SveMed+ (search date: November
30, 2010), CINCH (search date: November 30, 2010) , NCJRS
(search date: November 30, 2010), SpringerLink (search date: Oc-
tober 2, 2010), Wiley Interscience (search date: October 2, 2010),
DrugScope Library (search date: October 2, 2010), Electronic Li-
brary of theNational Documentation Centre onDrug Use (search
date: October 2, 2010), Google Scholar, and Google (search date:
February 2, 2010). Year of publication was limited to 1983 and
later.
Databases were searched using a strategy developed incorporat-
ing the filter for the identification of RCTs (Higgins 2009) com-
bined with selected MeSH terms and free text terms relating to
substance abuse and motivational interviewing. The MEDLINE
search strategy was translated into the other databases using the
appropriate controlled vocabulary as applicable. The search strate-
gies for all databases are shown in Appendix 1.
We searched the following web sites and mailing lists:
Websites:
• www.motivationalinterview.org (bibliography updated
November 2009)
• http://nrepp.samhsa.gov/programfulldetails.asp?
PROGRAM_ID=182 (accessed June 7th, 2010)
• http://www.controlled-trials.com (accessed August 24th,
2010)
• http://clinicalstudyresults.org (accessed August 24th, 2010
• http://centrewatch (accessed August 24th, 2010).
Mailinglists:
• MINT-listserv; a mailing list available to members of
MINT (Motivational Interviewing Network of Trainers)
• Australian Criminology Listserv
• Campbell Crime& Justice Group Steering Committee
• Crimnet. http://www.law.usyd.edu.au/mailman/listinfo/
crimnet.
We had no language restrictions.
Searching other resources
References in obtained reviews and included primary studies were
searched (in June 2010) to identify new leads.
Data collection and analysis
Dealing with dependent data
When there was more than one intervention group that was com-
pared with a single control group, we did not include both com-
parisons in the same meta-analysis. When there were several fol-
low-up times, we categorised them into post, short, medium or
long follow-up as described above. In cases when there were data
from more than one follow-up time within one of our categories,
we used the mean value. When there was more than one measure
of the same outcome, we used the standardised mean value.
Selection of studies
The screening of studies proceeded in 3 levels. At Level 1, two
reviewers who were methodologists scanned the titles of each ref-
erence. Each reviewer scored either “promote to next level”, “ex-
clude” or “can’t tell”. Only if both reviewers scored “exclude” was
the reference excluded. If at least one reviewer scored “can’t tell”
or “include”, the reference was promoted to Level 2. At Level 2,
the titles and abstracts were read, and the same promotion rules
applied. References promoted to Level 3 were ordered in full text.
Two reviewers read the full texts and scored “include” or “exclude”.
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If there were disagreement, and the two reviewers could not agree,
a third reviewer decided whether to include the study.
Data extraction and management
Data from each study were extracted by two reviewers using a
specifically developed data extraction form (available on request).
The reviewers had full access to details about authors, institutions,
and journals at all times. The same rules for tackling disagreement
as at Level 3 applied. If information about primary outcomes or
other vital information was missing from the original reports, we
contacted the corresponding author by e-mail (up to three times)
in an attempt to retrieve the necessary data for the analysis. In
cases where effect size information could not be obtained from
the authors of the primary studies, we used effect size data from
published systematic reviews and meta-analyses, when available.
If necessary, we contacted the authors of the systematic reviews/
meta-analyses for additional information.
Assessment of risk of bias in included studies
The risk of bias assessment for RCTs and CCTs (controlled clin-
ical trials) in this review was performed using the six criteria rec-
ommended by the Cochrane Handbook (Higgins 2009). The rec-
ommended approach for assessing risk of bias in studies included
in Cochrane Reviews is a two-part tool, addressing six specific
domains (sequence generation, allocation concealment, blinding,
incomplete outcome data, selective outcome reporting, and other
issues). The first part of the tool involves describing what was
reported to have happened in the study. The second part of the
tool involves assigning a judgement , in terms of “low ”, “high”
or “unclear”, relating to the risk of bias for that entry. To make
these judgments we used the criteria indicated by the handbook
adapted to the addiction field.
Blinding of participants and providers was assessed as one item,
while blinding of outcome assessor was assessed as another item.
Incomplete outcome data (avoidance of attrition bias) were con-
sidered for all outcomes except for the drop out from the treat-
ment, which is very often the primary outcome measure in trials
on addiction. It is assessed separately for results at the end of the
study period and for results at follow up.
The criteria for assessing other bias were: differences between
groups at baseline, collateral and biological measurement to cor-
roborate self-reports of substance abuse, differences in providers’
time spent in training between conditions, and contamination of
conditions. In addition, we looked for other sources of bias in each
study.
Grading of evidence
The quality of evidence was assessed according to a systematic and
explicit method (Guyatt 2008). In order to indicate the extent
to which one can be confident that an estimate of effect is cor-
rect, judgments about the quality of evidence are made for each
comparison and outcome. These judgments consider study design
(RCT, quasi RCT or observational study), study quality (detailed
study design and execution), consistency of results (similarity of
estimates of effect across studies), precision of estimates, and di-
rectness (the extent to which people, interventions and outcome
measures are similar to those of interest). The following defini-
tions in grading the quality of evidence for each outcome are used:
High: further research is very unlikely to change our confidence in
the estimate of effect. Moderate: further research is likely to have
an important impact on our confidence in the estimate of effect
and may change the estimate. Low: further research is very likely
to have an important impact on our confidence in the estimate
of effect and may change the estimate. Very low: any estimate of
effect is very uncertain.
Measures of treatment effect
We compared the treatment and control groups for outcomes at
post-test and at different follow-up times. Post-intervention data
were collected immediately after the intervention ended. Short
follow-up was until (but not including) 6 months. Medium fol-
low-up was from 6 months until (but not including) 12 months.
Long follow-up was 12 months and longer. For dichotomous data,
we computed relative risks (risk ratios). For continuous data we
computed standardised mean differences. 95 percent confidence
intervals were used as measures of the amount of random errors
influencing the outcome estimations. We used the optimal in-
formation size (OIS) (Pogue 1997) for assessing whether there is
a sufficient sample size for concluding that there is a statistically
significant effect in a meta-analysis. Using a two-sided alpha of
0.01 and power of 0.95 we calculated that a total sample size of
1,786 is necessary for detecting a small standardised mean differ-
ence (SMD = 0.2). For SMDs of 0.5 (medium) and 0.8 (large),
the OIS are 290 and 116, respectively.
Unit of analysis issues
In cluster-randomised trials, the elements are groups of individuals
(e.g. prisons, geographical areas, clinics), rather than individuals
themselves. In such studies, care should be taken to avoid unit-
of-analysis errors. If there for instance are a total of 100 substance
abusers with 25 abusers in each of four clinics, and two clinics are
randomised to receive the intervention and the other two are ran-
domised to receive the control, the correct N to use in the analysis
is not 100 but smaller. The effective sample size of a single inter-
vention group in a cluster-randomised trial is its original sample
size divided by a quantity called the design effect. A common design
effect is usually assumed across intervention groups. The design
effect is 1+(m - 1)r, where m is the average cluster size and r is the
intra cluster correlation coefficient (ICC). If we include any cluster
randomised controlled trials in this review, we try to measure the
intra-cluster correlation. The total variance in the outcome can
be partitioned into variance between groups (VBG) and variance
within groups (VWG).The intra cluster correlation is calculated
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as VBG/(VBG+VWG). But the ICC is seldom reported in the
primary studies. The number of participants can be used in the
analyses if the ICC is used as a correcting factor. For dichotomous
data both the number of participants and the number experienc-
ing the event can be divided by the same design effect (Higgins
2008).
Dealing with missing data
We contacted authors by email (up to three times) to collect miss-
ing data. Statisticians often use the terms ‘missing at random’, and
‘not missing at random’ to represent different scenarios. Data are
said to be ‘missing at random’ if the fact that they are missing is
unrelated to actual values of the missing data. Data are said to be
‘not missing at random’ if the fact that they are missing is related
to the actual missing data. In cases where we assumed that data
were missing at random, we analysed only the available data. If we
assumed that the data were not missing at random, we planned to
impute the missing data with replacement values, and treat these
as if they were observed. We planned to do this in different ways
and compare the results (e.g. last observation carried forward, im-
puting an assumed outcome such as assuming all were poor out-
comes, imputing the mean, imputing based on predicted values
from a regression analysis). For the included studies in this review
we did not impute data.
Assessment of heterogeneity
Statistically significant heterogeneity among primary outcome
studies was assessed with Chi-squared (Q) test and I-squared (Hig-
gins 2003). A significant Q ( p<.05) and I-squared of at least 50%
was considered as statistical heterogeneity.
Assessment of reporting biases
We used funnel plots for information about possible publication
bias. But asymmetric funnel plots are not necessarily caused by
publication bias (and publication bias does not necessarily cause
asymmetry in a funnel plot). Whenever asymmetry was present,
likely reasons were explored.
Data synthesis
When meta-analyses were performed, we reported random effects
meta-analyses. If meta-analyses were not judged to be appropriate,
we reported the results for each individual study.
Subgroup analysis and investigation of heterogeneity
We investigated the following factors with the aim of explaining
observed heterogeneity (if present): Students or non-students as
participants, type of fidelity check, type of substance, intensity or
length/period of the intervention, whether Intervention was MI
or MET, whether a manual was used, profession of therapist. We
also compared results for studies with or without the developers
of MI William R. Miller or Stephen Rollnick on the author list or
mentioned as mentors or trainers (including training by a member
of MINT [Motivational Interviewing Network of Trainers]). We
analysed effects separately for MI alone, MI integrated with other
therapy, and MI given as a prelude to other therapy.
When there weremany primary studies, we classified them accord-
ing to these variables in order to identify possible sources of het-
erogeneity. We considered performing moderator analyses (strati-
fication on subgroups, meta-analysis analogue to ANOVA, meta-
regression) to explore how observed variables were related to het-
erogeneity.
Sensitivity analysis
When there was significant unexplained heterogeneity and the
number of included studies was sufficient (more than 10), we as-
sessed the impact of differing risk of bias by sensitivity analyses.
The following sensitivity analyses were planned a priori: Genera-
tion of allocation sequence, concealment of allocation, blinding of
patients and providers, blinding of assessors, incomplete outcome
data addressed, selective reporting, and other bias.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
See Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Our electronic search in November 2009 returned 1,801 records,
and an updated search in November 2010 produced an ad-
ditional 518 records. One record (Emmen 2005) was located
through www.motivationalinterview.org. No additional records
were found while searching reference lists of included studies (in
June 2010), thus making the total 2,320. We excluded 2077
records on the basis of title and abstract. We acquired full reports
of 243 records (describing 208 studies). A total of 153 excluded
records (describing 149 studies) are listed in the Characteristics of
excluded studies.
Included studies
We identified 59 studies (reported in 90 articles) published be-
tween 1993 and 2010 for inclusion in this review, covering 13,342
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participants. 57 studies were RCTs, and two studies were quasi-
RCTs (Bazargan-Hejazi 2005; Freyer-Adam 2008). We did not
locate any cluster-RCTs. Full details of all the included studies are
given in a table (Characteristics of included studies). In 29 studies
the participants seemed to be exclusively alcohol abusers, and in
eight studies they were cannabis abusers. In four studies the par-
ticipants were exclusively cocaine abusers, and in the remaining 18
studies, the participants were abusing more than one substance.
We were not able to assess the severity of substance abuse across
studies from the information reported in the included articles.
There were 44 studies from the USA, five from Australia, three
each from the Netherlands and UK, two from Canada, and one
each from Germany and New Zealand.
Excluded studies
We excluded 149 studies (reported in 153 articles) read in full
text. 39 studies did not report fidelity checks using video- or audio
recordings. For 31 studies, substance abuse was not an outcome,
and 28 studies did not seem to have given MI, MET or AMI.
There were 21 studies that were not randomised trials, and 14
were not individualized, face-to-face interventions. Nine studies
did not have substance abusers as participants, three studies did
not compare MI with another condition, one study recruited and
treated participants with one session MI in an emergency room,
and two publications reported no results. One study had use of
prescription drugs as outcome. The excluded trials are listed in
the table Characteristics of excluded studies, with main reasons
for their exclusion.
Risk of bias in included studies
Full details of risk of bias assessments are given for each trial within
the Characteristics of included studies table. Overall summary
results of all the risk of bias assessments are displayed in Figure 1.
A summary of the risk of bias for each study and each domain is
given in Figure 2.
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
28 studies were at low risk of selection bias because they used an
adequate method of sequence generation, but for 29 studies the
generationmethod is unclear. Aminority of studies have obviously
not used adequate generation of allocation (n=2). For most of the
studies there is an inadequate description of what, if anything, was
done to conceal the allocation (n=50) and were therefore judged
as having unclear risk of bias.
Blinding
In psychological therapies like MI, it is not possible to blind the
people giving the intervention. It is also not generally possible to
blind the participants. An exception might be if there is an active
control, like another type of psychological therapy. In 27 of the
59 studies we believe that there was a high risk of bias because
participants and/or providers knew who were in the intervention
group. In the majority of studies (n=31) it was unclear whether
the assessors were blinded. In 22 studies the assessors appear to
have been adequately blinded.
For the primary outcomes we have treated physiological and non-
physiological outcomes separately. Non-blinding of physiological
outcomes produces less risk of bias than the non-physiological
ones. The secondary outcomes (retention in treatment, readiness
for change, and re conviction) were all non-physiological.
Incomplete outcome data
We used the following rules of thumb for the judgement of risk of
bias: loss-to-follow-up equal to or greater than20percent, different
rates of follow-up across intervention arms, reasons for loss-to-
follow-up not reported, and intention-to-treat not performed. 27
studies had adequately accounted for incomplete outcome data.
For 15 studies it was unclear, and for 17 studies there was a high
risk of bias for this item.
Selective reporting
Most studies (n=53) were judged to be free of selective reporting.
Other potential sources of bias
A small number of studies (n=12) was judged to have other po-
tential sources of bias. 21 studies were judged to be of low risk of
bias, and 26 studies were judged to be of unclear risk with respect
to other sources of bias.
Publication bias
Figure 3; Figure 4; Figure 5; Figure 6 show funnel plots of the
four main meta-analyses. For MI versus no intervention and for
MI versus treatment as usual, it appears that smaller studies tend
to have larger effect sizes in favour of MI. This could be (but not
necessarily) a sign of publication bias. There is a possibility that
small studies with non-significant results are less likely to be pub-
lished. For MI versus assessment and feedback and for MI versus
other active treatment, the funnel plots look more symmetric.
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Figure 3. Funnel plot of comparison: 1 MI versus no intervention, outcome: 1.1 Amount of substance use.
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Figure 4. Funnel plot of comparison: 4 MI versus treatment as usual, outcome: 4.1 Amount of substance use.
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Figure 5. Funnel plot of comparison: 2 MI versus assessment and feedback, outcome: 2.1 Amount of
substance use.
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Figure 6. Funnel plot of comparison: 3 MI versus other active intervention, outcome: 3.1 Amount of
substance use.
Effects of interventions
See: Summary of findings for the main comparison
motivational interviewing compared to no treatment control
group for substance abuse; Summary of findings 2 motivational
interviewing compared to treatment as usual for substance abuse;
Summary of findings 3 motivational interviewing compared
to assessment and feedback for substance abuse; Summary of
findings 4 motivational interviewing compared to other active
intervention for substance abuse
Of the 59 included studies, we were able to extract outcome data
from 55. For the remaining four studies (Parsons 2009; Rohsenow
2004; Stotts 2001; Thush 2009), the data in the articles were not
reported in the formof an effect size and it was not possible to com-
pute one, even after contacting the authors. Two studies (Walitzer
2008; Wood 2007) included two types of comparisons. The sub-
stance abuse outcomes were reported as a large number of differ-
ent outcomes (e.g. drinks per drinking day, number of abstinent
days, proportion of participants who were abstinent). Moreover,
for each outcome the data were reported in a number of ways (e.g.
means and SDs, number of events, p-values, F-values). We en-
tered all the data in Comprehensive Meta-Analysis 2.0 (Borenstein
2005), which can accept data input in 100 different formats, and
converted all outcome data into standardised mean differences. If
a study had more than one substance abuse outcome at the same
follow-up time or if a study reported the same outcome at more
than one follow-up within our follow-up categories, we computed
the mean. Finally, the data were entered into RevMan as generic
inverse variance data. As a control procedure, we have grouped the
outcomes into amount of use, frequency of use, and proportion
abstinent. These analyses did not reveal any significant differences
between the subgroups, and we do not report the results of meta-
analyses.
In the following we have divided comparisons into (1) MI versus
no intervention, (2) MI versus treatment as usual, (3) MI versus
assessment and feedback, and (4) MI versus other active interven-
tion. Within each comparison we have subgroups according to
follow-up time: (a) post-intervention, (b) short follow-up until 6
months, (c) medium follow-up 6-12 months, and (d) long follow-
up of 12 or more months.
Comparison 1: MI versus no intervention
There were 24 studies that compared MI with a no-treatment
control.
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Primary outcomes
1.1 Extent of substance use:
Post-intervention: Four studies, 202 participants showed thatMI
did significantly better than the control on reducing the amount
of substance use with a standardized mean difference of 0.79 (95%
CI 0.48, to 1.09). Heterogeneity was low (I-square: 1%). Short
follow-up: 15 studies, 2327 participants, showed that MI did
significantly better than the control group SMD 0.17 (95% CI
0.09 to 0.26). There was some variability in effect sizes (Chi-
squared =18.4, df=14, P=0.19, I-square = 24%), but not exceeding
our predetermined criteria for significant heterogeneity.Medium
follow-up:Twelve studies, 2326 participants, showed a significant
difference in favour of MI SMD 0.15 (95% CI 0.04 to 0.25). The
results varied somewhat (Chi-squared =14.06, df=11, I-squared =
22%) but again not exceeding our criteria. Long follow-up:One
study, 363 participants, found no significant differences between
the groups SMD 0.06 (95% CI -0.16 to 0.28). See Analysis 1.1
Secondary outcomes
1.2 Readiness for change:
Five studies (Analysis 1.2) . There was no significant effect SMD
0.05 (95%CI -0.11 to 0.22), and heterogeneity wasmoderate with
I-square of 48%.
1.3 Retention in treatment:
Five studies considered this outcome, but we could only compute
effect sizes for two studies, 427 participants (Analysis 1.3). The
effect was not significant SMD 0.26 (95%CI -0.0 to 0.52).
Comparison 2. MI versus treatment as usual (TAU)
Primary outcomes
2.1 Extent of substance use:
en studies considered this outcome . Post-intervention: Nine
studies, 1495 participants, showed a non-significant effect SMD
0.01 (95% CI -0.09 to 0.11) with an I-squared of 0%. Short fol-
low-up: Ten studies, 2102 participants, showed a non-significant
effect SMD 0.01 (95% CI-0.08 to 0.10]) with an I-squared of
0%. Medium follow-up: Five studies, 890 participants, showed
a non-significant effect 0.08 (95% CI -0.05 to 0.21]) with an I-
squared of 0%. See Analysis 2.1
Secondary outcomes
2.2 Retention in treatment:
Five studies reported retention in treatment, but we were able to
compute an effect size for only four of them, 1354 participants
(Analysis 2.2). The effects were heterogenous (I-sqared: 64%) and
not significant SMD -0.11 (95%CI -0.41 to 0.19]).
Comparison 3. MI versus assessment and feedback
Primary outcomes
3.1 Extent of substance use:
Short follow-up:There were seven studies, 986 participants, that
compared MI with a group that was only assessed and/or received
feedback with substance abuse outcomes at short follow-up . The
overall effect was not significant SMD0.12 (95%CI -0.01, 0.24).
The studies were homogenous (I-squared = 0%).Medium follow-
up: There were two studies, 265 participants, with outcomes at
medium follow-up, and the effect was significant in favour of MI
SMD0.38 (95%CI 0.10 to 0.66]). I-squaredwas 0%. See (Analysis
3.1)
Secondary outcomes
One study (Bien 1993) reported retention in treatment for a com-
parison between MI and assessment and feedback. We were not
able to compute an effect size. No studies reported readiness to
change for this comparison
MI versus other active intervention
Primary outcomes
4.1 Extent of substance use:
Therewere 13 studies that comparedMIwith a group that received
another active intervention . Post-intervention: Two studies, 185
participants, found a non-significant effect SMD-0.07 (95%CI
-0.37 to 0.23]) with an I-squared of 0%. Short follow-up: 12
studies, 2137 participants, found a non-significant effect SMD
0.02 (95%CI -0.07 to 0.12]) with an I-squared of 0%. Medium
follow-up: six studies, 1586participants, showed anon-significant
effect SMD-0.02 (95%CI-0.16 to 0.13]) with an I-squared of
41%. Long follow-up: Two studies, 437 participants, showed a
non-significant effect SMD -0.03 (95%CI -0.21 to 0.14]) with
and I-squared of 0%. See (Analysis 4.1)
Secondary outcomes
4.2 Readiness for change:
A meta-analysis of the two studies, 350 participants, on readiness
for change showed an SMD of -0.03 with a 95% confidence inter-
val from -0.24 to 0.18 (Analysis 4.2). The results were homoge-
nous (I-squared: 0%). One study (Winhusen 2008) had assessed
readiness for change, but we were not able to compute an effect
size. No study reported repeat convictions as an outcome.
4.3 Retention in treatment:
Five studies, 447 participants, reported retention in treatment (
Analysis 4.3). The effect was not significant SMD 0.01 (95%CI -
0.45 to 0.47). I-squared was 73%.
Subgroup analyses
We did not perform any subgroup analyses because no meta-anal-
ysis was significantly heterogeneous.
Sensitivity analyses
We did not perform any sensitivity analyses because no meta-
analysis was significantly heterogeneous.
Grading of the evidence
The summary of findings tables 1-4 (Summary of findings for the
main comparison, Summary of findings 2, Summary of findings
3, Summary of findings 4 ) show that the evidence was mostly of
low quality. A few of the comparisons were of moderate quality.
The downgrading of the evidence was undertaken because of risk
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of bias in the design of the studies. The randomisation was unclear
in many studies. Lack of blinding of participants, providers, and
outcome assessors could have caused bias, especially for the non-
physiological outcomes. There was also some uncertainty regard-
ing incomplete outcome reporting, selective reporting, and other
possible bias. Apart from the problems with risk of bias, the consis-
tency, precision, and directness were not downgraded. There were
no large effects. Dose-response gradients or plausible confounders
were not discernable.
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D I S C U S S I O N
Summary of main results
Extent of substance abuse
The main finding of this review is that compared to a no treat-
ment control MI has shown a significant effect on extent of
substance abuse. The effect was strongest at post-intervention
SMD 0.79 (95%CI 0.48 to 1.09) and weaker at short follow-up
SMD0.17 (95%CI 0.09 to 0.26]), and medium follow-up SMD
0.15 (95%CI 0.04 to 0.25]). For long follow-up, the effect was
not significant SMD 0.06 (95%CI -0.16 to 0.28).
MI did better than assessment and feedback for medium follow-
up regarding extent of substance abuse SMD 0.38 (95%CI0.10,
0.66]). For short follow-up, there was no significant effect of MI
SMD 0.12 (95% CI -0.01 to 0.24]). We found no data on the
effect of MI vs assessment and feedback for post-treatment or for
follow-up times longer than 12 months.
There was no significant difference between MI and other active
intervention at any follow-up time on extent of substance abuse.
Neither was there a difference betweenMI and treatment as usual.
Type of substance and level of substance use
We were interested in studying whether MI is more effective in
treating abuse of one type of substance (e. g. alcohol) versus other
types of substances (e.g. cocaine), but there were not enough stud-
ies to perform such comparisons. We also wanted to summarize
possibly different effects of MI on severe abuse versus less severe
abuse, but we were not able to assess severity across studies from
the available information reported in the included articles.
Secondary outcomes
There were not enough data to conclude about the effects ofMI on
retention in treatment, readiness to change, or repeat convictions.
Overall completeness and applicability of
evidence
We believe that we have obtained most of the existing evidence
from randomised controlled trials on the effects of motivational
interviewing on substance abuse published through 2010. The
research field is highly active with new randomised studies being
published almost monthly. Because of this, it is difficult for this
Cochrane review to be up to date all the time. The web site moti-
vationalinterview.org is a continuous source of information about
new publications, and the Motivational Interviewing Network of
Trainers (MINT) is an addition to electronic literature searches. A
more serious problem is that the trials mostly try to measure spe-
cific effects of MI. Among both clinicians and researchers, there
seems to be a tacit overemphasis on the importance of treatment
method and less focus on the impact of the individual who delivers
the treatment (therapist) and who receives it (the patient). By the
same token, some studies may have failed to pay sufficient atten-
tion to whether the patient and/or therapist is positive towards
the treatment and whether they like and respect each other. We
believe that MI certainly has large nonspecific effects, which may
be much larger than the specific ones (Walach 2001).
Quality of the evidence
We strived to include only evidence from high-quality randomised
controlled trials with integrity checks.Nevertheless, there are some
inherent problems with research in this field. One possible source
of bias is that it is impossible to blind therapists to treatment
condition. And it is almost impossible to blind the patients.
Potential biases in the review process
There may not always be good correspondence between the
methodological quality of a study and the quality of reporting of
the study. Most scientific journals have strict word limits on ar-
ticles, so authors of papers may have been unable to report im-
portant information about the study. We have applied stringent
criteria when grading the evidence. Other reviewers might have
reached other conclusions about the strength of evidence, but we
have aimed for being explicit and transparent regarding the judge-
ments leading to our decisions.
Agreements and disagreements with other
studies or reviews
We found a moderate effect size for comparisons between MI and
no intervention, while there were no differences between MI and
other active treatments. This has also previously been reported by
Burke (Burke 2003; Burke 2004). Similarly, our range of effect
sizes are compatible with Dunn et al’s (Dunn 2001) range of effect
sizes. Dunn also found that most comparisons between MI and a
no-treatment control favoured MI. The meta-analysis by Lundahl
et al (Lundahl 2010) reported an effect size of g=0.28 for MI
against weak comparison groups, similar to our findings. Lundahl
found g=0.09 for comparisons with other active interventions,
which is also close to what we have found. In common with us,
Hettema et al (Hettema 2005) reported a large variation in effect
sizes across studies.
Motivational interviewing is a brief intervention.With only one to
four sessions, one should not expect too much regarding changes
in drug abuse outcomes. Nevertheless, results from randomised
controlled trials have shown that MI compared to no intervention
or minimal intervention can significantly reduce drug and alcohol
consumption. When MI is compared to other interventions such
as giving feedback on assessments or other types of psychotherapy,
MI has not shown any superiority (or inferiority). This is proba-
bly because MI shares with these other interventions a number of
nonspecific therapeutic factors such as attention and therapeutic
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alliance. These factors may have a much greater influence on out-
come than the contribution made by approach-specific theory and
technique; in Lambert’s (Lambert 1986) review of empirical stud-
ies, common therapeutic factors accounted for 30% of the ther-
apeutic effect, technique 15%, expectancy (placebo-effect) 15%
and spontaneous remission 40%.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Motivational interviewing is a brief intervention, typically lasting
for 1-4 sessions. If therapists are comfortable with this style of
working with clients they should feel confident that providing MI
will be more effective than doing nothing. But if they for instance
prefer giving cognitive behavior therapy (CBT), the evidence (of
low to moderate quality) is too weak to conclude that CBT will
be more effective, equally effective or less effective than MI.
Implications for research
This is a fieldwhere there is no lack of randomised controlled trials.
Perhaps it is time to move from only studying whetherMI works
to also studying how it works, that is to study the mechanisms
behind MI. Apodaca and Longabaugh (Apodaca 2009) have e.g.
published a review in which they collected empirical data from
various parts of the causal chain in a model that they developed.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Anton 2005
Methods RCT.
Participants 160 outpatient alcoholics from the USA.
Interventions 1. naltrexone + MET (n= 41)
2. placebo + MET (n= 39)
3. naltrexone + CBT (n= 39)
4. placebo + CBT (n= 41)
Outcomes Physiological primary: Blood GGT, CDT, urine drug screen.
Non-physiological primary: Number relapsed, drinks per drinking day, percent absti-
nent.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were randomly assigned to 1 of 4 treatment condi-
tions”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used to
validate self-reports, and not likely to be influenced by lack of
blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 15% attrition at 12 weeks post-treatment. Balanced across con-
ditions. Reasons addressed. ITT performed. “All outcome anal-
yses were conducted under an intent-to-treat analysis plan on
all subjects who had at least 1 postrandomization outcome mea-
surement.”
Selective reporting (reporting bias) Unclear risk The published report included all expected outcomes based on
the stated hypotheses.
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Anton 2005 (Continued)
Other bias Low risk Used collateral and biological measurement to corroborate self-
reports of substance use. There were no differences between
groups at baseline. No additional sources of bias appear to be
present.
Ball 2007a
Methods RCT.
Participants Community sample of 98 non-dependent heavy drinking adults from the USA.
Interventions 1. brief MET (n= 34)
2. brief coping skills (n= 35)
3. wait-list control (n= 29)
Outcomes Physiological primary: Alcohol breath testing.
Non-physiological primary:Frequency of days drinking, amount of drinks per drinking
day.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...participants were randomised to a 3-week waiting list control
(WLC) group or one of twomanual-guided brief interventions.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used to
validate self-reports, and not likely to be influenced by lack of
blinding. The non-blinding may have caused bias regarding the
interviews, but the hand-held computer assessment is unlikely
to have caused bias.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7% attrition at 3 weeks post-treatment. Balanced across condi-
tions. Used ITT and the non-completers were all accounted for.
Selective reporting (reporting bias) Unclear risk The published report included all expected outcomes based on
the stated hypotheses.
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Ball 2007a (Continued)
Other bias Low risk Alcohol breath testing used as check of self-report. Differences
between groups at baseline were not reported. No additional
sources of bias appear to be present.
Ball 2007b
Methods Multisite RCT (5 sites).
Participants 461 outpatients from five outpatient substance abuse programs in the USA.
Interventions MET (n= 216) vs. counselling as usual (n= 245).
Outcomes Physiological primary: Urinary drug analysis.
Non-physiological primary: Days per week of primary substance use.
Secondary: Retention in treatment (days enrolled at treatment program, % enrolled at
program at 4-month follow-up).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation used a computerized program...This
program involved a process of urn allocation”.
Allocation concealment (selection bias) Unclear risk “The randomisation used a computerized program that was
managed by off-site personnel, but accessed locally by a re-
search staff who communicated the assigned therapy condi-
tion”.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used
to validate self-reports, and not likely to be influenced by lack
of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 32% attrition at 8 weeks post-treatment. 32% attrition at 16
weeks post-treatment. “There were no significant differences
between therapy conditions or Therapy condition x Program
Site interactions in the rates of follow-up or in the presence or
frequency of missing data points.” Reasons for loss-to-follow-
up are not stated. The researchers performed an intention-
to-treat analysis.
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Ball 2007b (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the stated hypotheses.
Other bias High risk Time spent in training was not balanced across conditions.
Some contamination of therapy conditions may have oc-
curred. Differences between groups at baseline were not re-
ported.
Barnett 2007
Methods RCT.
Participants 225US college students referred to attend alcohol education following an alcohol-related
incident.
Interventions Brief MI (n= 112) vs. computer-delivered education (Alcohol 101 CD ROM, [n=113])
.
Outcomes Physiological primary: None.
Non-physiological primary:Number of drinking days, number of heavy drinking days,
average number of drinks per drinking day, average estimated BAC, alcohol problems.
Secondary: Motivation to change alcohol use (Contemplation Ladder).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table.
Allocation concealment (selection bias) Unclear risk “The counsellor opened an envelope containing the baseline
condition assignment, prepared by the project coordinator”. It
remains unclear whether envelopes were sequentially numbered,
opaque and sealed.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “A research assistant who was blind to intervention condition
conducted the 3- and12-month follow-up assessments in person,
or by phone and mail...”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 5% attrition at 3 months follow-up and 6% attrition at 12
months follow-up with no differences between conditions. Rea-
sons for missing data not stated. ITT not performed.
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Barnett 2007 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Unclear risk Only self-reported outcomes. There were no differences between
groups at baseline.
Bazargan-Hejazi 2005
Methods Quasi-RCT.
Participants 295 emergency department patients 18 years or older who screened positive for at-risk
drinking. USA.
Interventions Brief MI + booster telephone call at 10 days post enrolment (n = 144) vs usual care (n=
151).
Outcomes Physiological primary: None.
Non-physiological primary:Drinks per drinking day, more than 6 drinks per occasion
at least weekly, and AUDIT score.
Secondary: None.
Follow-up was 3 months after enrolment.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Each of the 3 health promotion advocates performed random
allocation for their own enrollees, assigning the first participant
by a flip of a coin, and alternating status thereafter.”
Allocation concealment (selection bias) High risk “Each of the 3 health promotion advocates performed random
allocation for their own enrollees, assigning the first participant
by a flip of a coin, and alternating status thereafter.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “To guard against interviewer bias and to ensure that health pro-
motion advocates were blinded to the patients’ randomization
allocation for the 3-month follow-up assessments, enrolleeswere
not followed up by the same health promotion advocate who
assessed them initially. Patients were notified not to reveal their
group assignment to any project staff at any time.”
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Bazargan-Hejazi 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 37% attrition at the 3 month follow-up, balanced between
groups. Reasons for attrition explained. ITT was not performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias High risk Only self-reported outcomes. The intervention group had a
higher rate of drug use and lower mean age at baseline.
Bell 2007
Methods RCT.
Participants 60 veterans enrolled in substance abuse treatment at the New Mexico Veterans Affairs
Health Care System, USA.
Interventions MI + TAU (n=40) vs TAU (n=20).
Outcomes Physiological primary: None.
Non-physiological primary: Drinks per day, number of drinking days, percent within
safe drinking limits, substance use per day, and number of substance use days.
Secondary: None.
Follow-up was at 2 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were assigned to condition by a computerized urn
randomisation program which balanced for distribution to the
groups by the following factors: age, education, presence or ab-
sence of history of head injury with loss of consciousness, gen-
der, and enrolment (yes/no) in the six standard treatments...”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
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Bell 2007 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 22% were lost to follow-up at 2 months. Not ITT. Reasons for
loss to follow-up stated, but reasons for removal were that they
were disqualified because of lack of baseline drinking (n=7). Loss
was balanced.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias High risk Only self-reported outcomes. More females received MI.
Bernstein 2009
Methods Pilot RCT.
Participants 210 patients aged 14-21 years in an urban, academic paediatric emergency department.
USA.
Interventions Brief MI (n = 68) vs assessed control (n=71) vs non assessed control (n = 71).
Outcomes Physiological primary: None.
Non-physiological primary:Marijuana consumption including a 30-day self-report of
marijuana use, attempts to quit, cut back, or change conditions of use, and risk factor
questions repeated at follow-up.
Secondary: None.
Follow-up was at 12 months.
Notes We do not report data on the non assessed control because baseline data on this group
were not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was based on computer-generated random
numbers in blocks of 100 stratified by age group (14-17 and 18-
21 years).”
Allocation concealment (selection bias) Low risk “A double opaque envelope system enabled blinding of the re-
search assistants who performed the assessment to randomisa-
tion status. The first envelope, with randomisation to assessed
(Int, AC) or non assessed (NAC) status, was opened immedi-
ately after enrolment. A second envelope indicating Int or AC
status was not opened until after assessment.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
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Bernstein 2009 (Continued)
Blinding (performance bias and detection
bias)
Assessors
Low risk “Participants were cautioned not to reveal to the research assis-
tants at the time of follow-up whether or not they had received
any further testing after enrolment”
Incomplete outcome data (attrition bias)
All outcomes
High risk 30% lost to follow-up at 3months in the assessed groups, not bal-
anced between groups. 29% lost to follow-up at twelve months
across all groups, not balanced across groups. Reasons for loss
not stated. Not ITT, but worst-case scenario analysis.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias High risk Only self-reported outcomes. The intervention group usedmar-
ijuana on more days per month than the AC group at baseline.
Bien 1993
Methods RCT.
Participants 32 US outpatients from VA outpatient substance abuse treatment program.
Interventions Brief MI + standard outpatient treatment (n= 16) vs. attention placebo interview +
standard outpatient treatment (n= 16).
Outcomes Physiological primary: None.
Non-physiological primary: SEC (standard drink units), BAL, percent days abstinent.
Secondary: VA treatment attendance.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...half were assigned at random to receive a motivational inter-
view, while the rest served as a control group.”
Allocation concealment (selection bias) Unclear risk “...the experimenter opened a sealed envelope...” It is not stated
whether the envelopes were sequentially numbered or opaque.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Low risk Assessors “were kept blind to group assignment”.
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Bien 1993 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 19% attrition at 6 months follow-up, balanced between groups.
Reasons for attrition explained. Unclear whether ITT was per-
formed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Low risk Collateral report as check of self-report. There were no differ-
ences between groups at baseline. No additional sources of bias
appear to be present.
Borsari 2005
Methods Multisite RCT (2 sites).
Participants 64 US students mandated to a substance use prevention program.
Interventions Brief MI (n= 34) vs. alcohol education session (n= 30).
Outcomes Physiological primary: None.
Non-physiological primary: Drinks per week, binge drinking episodes, typical BAC,
peak BAC, RAPI.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly assigned”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk 11% loss-to-follow-up after 3months and 25% lost to follow-
up after 6 months. Balance in numbers not stated. Reasons
for missing data not stated. ITT not performed.
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Borsari 2005 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the stated hypotheses.
Other bias Unclear risk Collateral report as check of self-report. There were baseline
differences in AUDIT, typical BAC, and number of drinks
per week.
Brown 2010
Methods RCT.
Participants 184 men and women who had been driving while impaired (DWI) with drinking prob-
lems, who were recidivists, and who were not currently engaged in DWI interventions.
Canada.
Interventions Brief MI (n= 92) vs. information-advice (n= 92).
Outcomes Physiological primary: Biomarkers of alcohol abuse (GGT, AST, ALT, MCV) by blood
assay.
Non-physiological primary: Alcohol abuse-related behaviours (percent risky drinking
days) using the MMPI-Mac Scale.
Secondary: Subsequent substance abuse treatment service utilization (data not reported)
.
Readiness to change.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerized urn randomisation.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk “Participants, interviewers who administered the baseline and
follow-up assessments, the statistician who conducted the initial
analyses to test themainhypotheses, and investigatorswere blind
to participant assignment.”
Blinding (performance bias and detection
bias)
Assessors
Low risk “Participants, interviewers who administered the baseline and
follow-up assessments, the statistician who conducted the initial
analyses to test themainhypotheses, and investigatorswere blind
to participant assignment.”
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Brown 2010 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7% were lost after randomisation and intervention. They were
excluded from further analyses (not intention to treat). No rea-
sons for attrition. A further 6% were lost and data were esti-
mated.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Low risk Threat of invalidity in self-report was addressed by corrobora-
tion from bio markers and measurement of social desirability
in response styles. There were no differences between groups at
baseline.
Carey 2006
Methods RCT.
Participants 509 US heavy drinking students.
Interventions 1. Timeline Follow-Back control (n= 89)
2. TLFB basic MI (n= 87)
3. TLFB enhanced MI (n= 86)
4. control (n= 81)
5. basic BMI (n= 85)
6. enhanced BMI (n= 81).
Outcomes Physiological primary: None.
Non-physiological primary:Drinks per week, drinking per drinking day, heavy drink-
ing frequency, peak BAC, RAPI score.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Assigned randomly”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
51Motivational interviewing for substance abuse (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Carey 2006 (Continued)
Blinding (performance bias and detection
bias)
Assessors
High risk Assessors “were not blind to condition.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 3% lost to follow-up at one month, 23% at 6 months and 22%
at 12 months. Balanced across conditions. Reasons for missing
data addressed but not detailed. Unclear whether ITT was used.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Low risk Collateral report as check of self-report. There were no differ-
ences between groups at baseline. No additional sources of bias
appear to be present.
Carroll 2006a
Methods Multisite RCT (5 sites).
Participants 423US substance users entering outpatient treatment infive community-based treatment
settings.
Interventions MI + standard intake evaluation (n= 173) vs standard intake evaluation (n= 178).
Outcomes Physiological primary: Urine test + breath test.
Non-physiological primary: Days of use of primary substance.
Secondary: Readiness for change (URICA [data not reported]).
Retention in treatment (percent retained at site, number of sessions completed).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...participants were randomised to condition (MI or stan-
dard evaluation) using an urn randomisation.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used
to validate self-reports, and not likely to be influenced by lack
of blinding.
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Carroll 2006a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 24% attrition at one month, 27% attrition at 3 months bal-
anced by condition. No reasons for attrition reported. ITT
not done.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the stated hypotheses.
Other bias Unclear risk Urine and breath samples to check on self-report. Time spent
in training was not balanced across conditions, and clinicians
assigned toMI receivedmore training and supervision. There
were no differences between groups at baseline.
Carroll 2006b
Methods RCT.
Participants 136 US marijuana-dependent young adults referred by the criminal justice system.
Interventions 1. MET/contingency management (n= 33)
2. drug counselling/contingency management (n= 34)
3. MET (n= 35)
4. drug counselling (n= 33).
Outcomes Physiological primary: Marijuana positive urine specimens (%).
Non-physiological primary:Days ofmarijuana use (%), longest duration of continuous
abstinence,
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...were randomised to one of the four treatment conditions”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used to
validate self-reports, and not likely to be influenced by lack of
blinding.
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Carroll 2006b (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 38% attrition at 3 months and 21% attrition at 6 months. Im-
balance between groups. Reasons for missing data not stated.
ITT was performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Low risk Urine toxicology screens and breath samples to check on self-
report. There were no differences between groups at baseline.
No additional sources of bias appear to be present.
Carroll 2009
Methods Multisite RCT (5 sites) in the USA.
Participants 436 Hispanic substance abusers from the USA.
Interventions MET (n = 214) vs counselling as usual (n =222).
Outcomes Physiological primary: Percent positive urine specimens.
Non-physiological primary: Days of substance use by week, percent days abstinent
from alcohol.
Secondary: Treatment retention (days enrolled in treatment at community treatment
program through week 16).
Notes The design paralleled that of Ball 2007b.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn allocation.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiolog-
ical and also used to validate self-reports, and not
likely to be influenced by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether asses-
sors were blinded. But most outcomes were phys-
iological and also used to validate self-reports, and
not likely to be influenced by lack of blinding.
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Carroll 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 28 % lost to follow-up. Reasons for attrition not
described but similar between groups. Not ITT
even though they reported an intention to treat
sample.
Selective reporting (reporting bias) Low risk The published report included all expected out-
comes based on the stated hypotheses.
Other bias Unclear risk Only self-reported outcomes.Differences at base-
line were not reported.
Chanut 2007
Methods Pilot RCT.
Participants 51 offenders convicted of driving under the influence (DUI). Canada.
Interventions MI (n = 24) vs psycho-education (n =27).
Outcomes Physiological primary: None.
Non-physiological primary: Heavy drinking days (>6 units/day) and AUDIT.
Secondary: Service utilization.
Follow-ups were at 3 months and 6 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn randomisation (“Un protocole de randomisation par urnes
assisté par ordinateur (Project MATCH Research Group, 1993)
a été utilisé pour assigner les participants à l’une des deux con-
ditions.”).
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition was 22% at 3 months and 29% at 6 months. Balanced
across groups. Reasons for loss to follow-up not reported. Use of
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Chanut 2007 (Continued)
ITT was reported but it is unclear whether all reported analyses
used ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Unclear risk Used collaterals to verify self-report. There were baseline differ-
ences in days of hazardous drinking and the Drug Abuse Screen-
ing Test.
Connors 2002
Methods RCT.
Participants 126 US clients entering outpatient alcoholism treatment.
Interventions MI (n =40) vs Role induction (n = 37) vs non-preparatory session control group (n =
36).
Outcomes Physiological primary: None.
Non-physiological primary: Abstinent days, heavy drinking days.
Secondary: Retention in treatment (therapy session attendance).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Clients were randomly assigned to one of three preparatory
intervention conditions”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 13 (10%) did not provide Timeline Follow-Back Interview data
at the 12 month point. Of these 13, 12 actively withdrew from
the study or ceased cooperation with follow-up efforts and 1
moved and could not be located. We do not know the attrition
for the post-treatment and the 3, 6, and 9 month follow-ups.
Balance between conditions was not stated and ITT was not
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Connors 2002 (Continued)
performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study purposes.
Other bias Low risk Collateral report to check on self-report. There were no differ-
ences between groups at baseline. No additional sources of bias
appear to be present.
Copeland 2001
Methods RCT.
Participants 229 Australian cannabis users.
Interventions 1. 6-session CBT (including elements of MI) (n= 78)
2. 1-session CBT (including elements of MI) (n= 82)
3. delayed treatment control group (n= 69).
Outcomes Physiological primary: None.
Non-physiological primary: Daily amount of cannabis use in last month, cannabis
dependence, proportion of cannabis related problems.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomised to one of three conditions”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely to be
influenced by lack of blinding due to validation with physiolog-
ical measurement.
Blinding (performance bias and detection
bias)
Assessors
Low risk “...follow-up was conducted by an independent researcher
”blind“ to the subject’s treatment allocation.”
Incomplete outcome data (attrition bias)
All outcomes
High risk 26% attrition at a median of 237 days follow-up (individual fol-
low-up durations, range: 102-553 days). Drop out was balanced
across groups. No reasons for drop-out were stated. “Analyses
were conducted on an intention-to-treat basis.” A best-case sce-
nario was reported.
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Copeland 2001 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study purposes.
Other bias High risk 17% had sought assistance to moderate their use in the time be-
tween their participation in this study and follow-up. They used
urinalysis of cannabinoid levels as a validation of self-reported
cannabis use. Differences between groups at baseline were not
reported.
D’Amico 2008
Methods Pilot RCT.
Participants 64 high-risk teens in a primary care clinic that provides health care for underserved
populations. USA.
Interventions 15 minutes of MI (n = 38) or usual care (n =26).
Outcomes Physiological primary: None.
Non-physiological primary: Number of days last month drank alcohol. Number of
times usedmarijuana on days used.Number of alcoholic drinks consumed on days drink-
ing. Number of days consumed more than 3 drinks. Number of days used marijuana.
Secondary: None.
Notes Project CHAT.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judgement.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Mailed questionnaire used for follow up.
Incomplete outcome data (attrition bias)
All outcomes
High risk 34% of those randomised did not complete the final survey
(unequal numbers). 8 participants did not want to participate,
but the rest could not be reached. No ITT.
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D’Amico 2008 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not reported.
De Wildt 2002
Methods Multisite RCT (14 sites).
Participants 248 Dutch patients meeting DSM-IV criteria for alcohol dependence or abuse.
Interventions 1. Acamprosate + MET (n= 86)
2. Acamprosate + CBT (n= 78)
3. Acamprosate (n= 77).
Outcomes Physiological primary: GGT.
Non-physiological primary:Number abstinent, number relapsed, time to first relapse,
number of abstinent days, rate of continuous abstinence.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Sealed envelope randomisation with balancing by blocks
of 15 was used to obtain equal numbers of patients per
treatment group from each centre.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk Noblinding, butmost outcomeswere physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 30% attrition at 6 months follow-up. Balanced drop-out
and reasons for drop-out stated. ITT completed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
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De Wildt 2002 (Continued)
Other bias High risk 23% of patients consulted some other professional for alco-
hol-related problems during the treatment. Blood samples
were drawn to check on self-report. There were no differ-
ences between groups at baseline.
Emmen 2005
Methods RCT.
Participants 123 Dutch patients who visited an outpatient clinic for problem drinking.
Interventions Dutch version of Drinker’s Checkup (n= 61) vs care as usual (n= 62).
Outcomes Physiological primary: Serum carbohydrate-deficient transferrin.
Non-physiological primary: Units per day in previous six months.
Secondary: Motivation to change.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...balanced block randomisation. The main researcher (M.J.E)
used sealed envelopes to generate the allocation sequence.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Not blinded, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 9% lost-to-follow-up at 6 months. Balanced drop-out. Reasons
stated. ITT performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Serum carbohydrate-deficient transferrin (CDT) was measured
(biological data). There were no differences between groups at
baseline. No additional sources of bias appear to be present.
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Feldstein 2007
Methods RCT.
Participants 55 US under aged heavy drinkers.
Interventions 1 session MI (n= 40) vs no treatment control (n= 15).
Outcomes Physiological primary: None.
Non-physiological primary: Binge drinking last 2 weeks, RAPI.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used a random number list.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Undergraduate assistants blind to the randomization collected
participant data at the follow-up.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7% lost-to-follow-up at 2 months, balanced across groups. Rea-
sons stated. Not ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not reported.
Freyer-Adam 2008
Methods Quasi-RCT.
Participants 595 general hospital patients. 25%were alcohol abusers, 57% at -risk drinkers, and 18%
heavy episodic drinkers. Germany.
Interventions 1. MI by liaison service (n= 249)
2. MI by hospital physicians (n= 121)
3.TAU (n= 225).
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Freyer-Adam 2008 (Continued)
Outcomes Physiological primary: None.
Non-physiological primary: Gram alcohol per day, gram alcohol past week.
Secondary: Readiness to change drinking.
Notes It was not possible to monitor the fidelity of the intervention in physician arm.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “...randomisation was conducted by time-frame, based on the
date of admission.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
High risk “...the staff was not blind to the study group to which the par-
ticipants had been assigned.”
Incomplete outcome data (attrition bias)
All outcomes
High risk 29% lost to follow-up at 12 months, not balanced, reasons pro-
vided. Not ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias High risk Only self-reported outcomes. Because staff becamemore experi-
enced over time, they might have recruited different patients in
the first period when they recruited the controls than in the later
period when they recruited to the intervention groups. There
were differences between groups at baseline on satisfaction with
health, age, and having an intimate partner.
Kadden 2007
Methods RCT (dismantling design).
Participants 240 adult marijuana smokers meeting DSM-IV criteria for cannabis dependence. USA.
Interventions 9 weeks of one of four conditions:
1. case management control condition (n= 62)
2. MET/CBT coping skills training (n= 61)
3. contingency management (n= 54)
4. MET/CBT + Contingency management (n= 63).
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Kadden 2007 (Continued)
Outcomes Physiological primary: None.
Non-physiological primary: Total 90-day continuous abstinence. Proportion of days
abstinent.
Secondary: Readiness to change (Readiness to Change Questionnaire).
Follow-up was at 2 months posttreatment.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerized urn randomisation.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely
to be influenced by lack of blinding due to validation with
physiological measurement.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Insufficient information to tell if assessor was blinded, but
the outcome measurements are not likely to be influenced
by lack of blinding due to validation with physiological
measurement.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 17% lost to follow-up with reasons stated. Different attri-
tion across groups. No ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes
based on the study purposes.
Other bias Low risk Urine samples were collected to check on self-report.
There were no differences between groups at baseline. No
additional sources of bias appear to be present.
Kahler 2004
Methods RCT.
Participants 48 US patients undergoing inpatient detoxification for alcohol dependence.
Interventions MET for 12-step involvement (n= 24) vs brief advice to attend AA (n= 24).
Outcomes Physiological primary: None.
Non-physiological primary: Percent of days abstinent, drinks per drinking day.
Secondary: AA/NA attendance and involvement.
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Kahler 2004 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Eight cohorts of 6 participants were run to obtain the desired
sample with treatment conditions for each cohort determined
randomly.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “RAs (research assistants) were blind to treatment assignment of
individuals and cohorts.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 48 were randomised. Attrition was 4%, 4%, 6%, 6%, 12%,
and 12% at 1,2,3,4,5, and 6 months follow-up, respectively. No
reasons for insufficient data reported. No ITT performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Collateral reports were used. However, because the two treat-
ments were of different length, it is not possible to deter-
mine whether treatment intensity rather than treatment content
caused the observed effects. There were no differences between
groups at baseline.
Kavanagh 2004
Methods RCT.
Participants 25 Australian inpatients with current misuse of non-opioid drugs.
Interventions Start Over and Survive (n= 13) vs standard care (n= 12).
Outcomes Physiological primary: None.
Non-physiological primary: Abstinent or improved on all substances.
Secondary: None.
Notes
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Kavanagh 2004 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...participants were allocated randomly to conditions using a
separate table of random permutations for each site.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “The final assessment was undertaken by research staff who were
blind to treatment conditions.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition was 4% at 6months and 32% at 12 months. Balanced.
We do not know the attrition at 6 weeks and 3 months. Reasons
for loss were not reported. ITT was performed.
Selective reporting (reporting bias) High risk Not separate results for AUDIT, Severity of Dependence Scale
and the Drug Check. Results for number abstinent and number
improved were collapsed.
Other bias High risk Only self-reported outcomes.Groupswere significantly different
at baseline. Because there was no contact control it is possible
that the positive results were due to contact alone. Participants in
the Start Over and Survive group had longer length of stay and
less confidence in controlling substance abuse, and were living
with fewer family members than participants in the standard
care group at baseline.
Kay-Lambkin 2009
Methods RCT
Participants 97 Australian people with comorbid major depression and alcohol/cannabis misuse.
Interventions Brief intervention for depressive symptoms followed by randomisation into 3 different
groups:
1. therapist-delivered MI/CBT (n= 35)
2. computer-delivered MI/CBT (n= 32)
3. no further treatment (n= 30)
Outcomes Alcohol/cannabis use and hazardous substance use index scores measured at baseline,
and 3, 6 and 12 months post-baseline assessment using the Opiate Treatment Index
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Kay-Lambkin 2009 (Continued)
(OTI) and the SCID-RV.
Notes In one condition, MI/CBT was delivered by computer (not considered in this review)
. Intervention is called SHADE therapy (Self-Help for Alcohol and other drug use and
Depression).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A permuted block randomisation approach was used so that the
distribution of participants across treatment conditions could
be maintained regardless of the final sample size.”
Allocation concealment (selection bias) Low risk “Treatment allocations were transferred from this list by an ad-
ministrative assistant and concealed in individual envelopes la-
belled with the relevant participant code. Neither of these pro-
cesses was conducted by personnel involved with the assessment
or treatment phases of the study. Prior to the BI session, the re-
search clinicians were issued with a new randomisation envelope
by the administrative assistant, which displayed the participant
number on the outside of the envelope with the treatment allo-
cation sealed inside. The envelope was opened by the participant
at the conclusion
of the BI session.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk Patients and providers were not blinded.
Blinding (performance bias and detection
bias)
Assessors
Low risk “At the conclusion of the treatment period all participants, re-
gardless of treatment completion, met with an independent re-
search clinician, blind to treatment allocation,
to complete follow-up assessments.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition was 16% at 3 months follow-up, 19% at 6 months,
and 16% at 12 months. Reasons provided. Not stated whether
attrition was balanced. ITT was performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not fully reported. Age and gender were similar.
No additional sources of bias appear to be present.
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Kelly 2000
Methods RCT.
Participants 32 Australian women with alcohol and marital problems.
Interventions Alcohol focused treatment (including MI, CBT strategies and relapse prevention) (n=
16) vs 1 month waiting list control group (n= 16).
Outcomes Physiological primary: None.
Non-physiological primary: Standard drinks per drinking day.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...assigned randomly.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk 28% attrition at 1 month, 31% attrition at 6 months, and 38%
attrition at the 12 months follow-up. Balanced across groups.
Not clear whether ITT was performed. Reasons for loss not
reported.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Collateral report to check on self-report. There were no differ-
ences between groups at baseline. No additional sources of bias
appear to be present.
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Maisto 2001
Methods Multisite RCT (12 sites).
Participants 301 hazardous alcohol using elderlyUS patients who presented for treatment at a primary
care clinic.
Interventions 1. MET (n= 101)
2. brief advice (n= 100)
3. standard care (n= 100).
Outcomes Physiological primary: None.
Non-physiological primary: Days abstinent, number of drinks, drinks per drinking
day, days 1-6 drinks.
Secondary: Readiness to change (Stages of Change Readiness and Treatment Eagerness
Scale [SOCRATES]). Data not reported.
Follow-up at 1,3,6,9, and 12 months.
Notes We do not have follow-up data on 1, 3, and 9 months.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table.
Allocation concealment (selection bias) Low risk “The schedule was kept in an envelope in a locked drawer
and was used only by the project coordinator.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition was 5%, 8%, 14%, 15%, and 17% at 1 month, 3
months, 6 months, 9 months, and 12 months, respectively.
Reasons for loss not reported. We don’t know if loss was
balanced across groups. No ITT reported.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
Other bias Low risk Collateral reports were used to check on self-report. There
were no differences between groups at baseline. No addi-
tional sources of bias appear to be present.
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MarijuanaTP 2004
Methods Multisite RCT (3 sites).
Participants 450 US cannabis dependent adults.
Interventions 1. 2 session MET (n= 146)
2. 9 session MET (n= 156)
3 4 month delayed treatment (n= 148).
Outcomes Physiological primary: None.
Non-physiological primary: Percent of days smoking, periods smoked per day, joints
per day, dependence symptoms, abuse symptoms, marijuana problems.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn randomisation.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely
to be influenced by lack of blinding due to validation with
physiological measurement.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk “Research assistants were not blinded to the participants’ ex-
perimental conditions.” But the outcome measurements are
not likely to be influenced by lack of blinding due to valida-
tion with physiological measurement.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up at 4months, 9months and 15 months were
11%, 13% and 17%, respectively. Balanced. No reasons for
loss reported. ITT performed (analysis of missing cases using
baseline values.)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
Other bias Unclear risk Collateral interviews and urine specimens to check on self-re-
port. Numbers of sessions were confounded with differential
content and process. Different expectancies of success were
created by the differences in treatment length. There were no
differences between groups at baseline.
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Marsden 2006
Methods Multisite RCT (5 sites).
Participants 342 UK adolescent and young adult stimulant users.
Interventions BMI (n= 166) vs written health risk information (n= 176).
Outcomes Physiological primary: None.
Non-physiological primary: Ecstasy number of days, ecstasy tablets, cocaine powder
number of days, cocaine g/day, crack number of days, crack g/day, cannabis number of
days, cannabis g/day, alcohol number of days, alcohol g/weekday, alcohol g/weekend.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “two-group randomised controlled trial”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely
to be influenced by lack of blinding due to validation with
physiological measurement.
Blinding (performance bias and detection
bias)
Assessors
Low risk “To guard against bias, all follow-up interviews were con-
ducted by a different worker from the one who administered
the participant’s recruitment protocol.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 13% attrition at 6 months follow-up, balanced across condi-
tions. Reasons not provided. “The analysis of outcome was
conducted on an intention-to-treat (ITT) basis (involving all
participants whowere randomly assigned) and baseline scores
were substituted for cases lost to follow-up.”
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
Other bias Low risk Stimulant toxicology testing on a random 30%. There were
no differences between groups at baseline. No additional
sources of bias appear to be present.
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Martin 2008
Methods RCT.
Participants 40 non-treatment-seeking adolescent cannabis users from Australia aged 14-19 years.
Interventions Two-session brief intervention (n= 20) vs a 3-month delayed-treatment control condition
(n= 20).
Outcomes Physiological primary: Urine test.
Non-physiological primary: Days of cannabis use, mean quantity of cannabis used
weekly, and number of DSM-IV dependence symptoms.
Secondary: None.
Notes Intervention is referred to as ACCU (Adolescent Cannabis Check-up).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation sequence was generated by a computer ran-
dom number generator.”
Allocation concealment (selection bias) Low risk “...participants were randomly allocated to one of the two condi-
tions by means of a sequence of labelled cards contained within
numbered sealed (opaque) envelopes that were prepared by an
independent researcher and opened in the presence of the par-
ticipant.”
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Participants were followed up by an independent researcher 3
months after their last involvement with the project.” Most out-
comes were physiological and also used to validate self-reports,
and not likely to be influenced by lack of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 20% were lost to follow-up. Equal attrition across groups. In-
tention to treat conducted. Reasons for attrition not reported.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study purposes.
Other bias Unclear risk Urinanalysis to validate self-report. The treatment group re-
ported significantly more days of cannabis use in the past 90
days than the control group.
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Martino 2006
Methods Pilot RCT.
Participants 44 dually diagnosed psychotic and drug-related disordered patients. USA.
Interventions Two sessions of MI (n=24) vs a two-session standard psychiatric interview (n=20).
Outcomes Physiological primary: None.
Non-physiological primary: Days of primary drug use, secondary drug use, alcohol
use.
Secondary: Retention in treatment.
Readiness to change (URICA). Data not reported.
Follow-ups were at posttreatment, 1, 2, and 3 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn randomisation.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Low risk “...two research staff members administered the assessments in
a non-blinded fashion.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 14% were lost to at least one follow up, balanced across groups.
Reasons for loss not stated. ITT performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study purposes.
Other bias High risk Only self-reported outcomes. There were differences at baseline
in alcohol composite score and legal involvement.
Mastroleo 2010
Methods RCT.
Participants 122 US heavy drinking college students.
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Mastroleo 2010 (Continued)
Interventions 1. peer counselled MI with supervision (n= 74)
2. peer counselled MI without supervision (n= 82)
3. no treatment control (n= 82).
Outcomes Daily Drinking Questionnaire (total drinks per week, peak BAC, heavy drinking be-
haviours).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No mention of allocation method.
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk Patient and providers were not blinded to treatment allocation.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 16% attrition at 3 months. Balanced. No reasons stated. ITT
(imputed missing data).
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study purposes.
Other bias Unclear risk Only self-reported outcomes. 61/156 (39%) of randomised par-
ticipants did not receive the intervention. Differences between
groups at baseline were not reported.
MATCH 1993
Methods Multisite RCT (9 clinical research units and a coordinating centre).
Participants 1726 US inpatients and outpatients.
Interventions Motivational Enhancement Therapy (MET) vs Cognitive Behavioral Therapy (CBT)
vs Twelve-Step Facilitation Therapy (TSF). Not reported how many people were ran-
domised to each condition.
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MATCH 1993 (Continued)
Outcomes Physiological primary: Gamma-glutamyl transferase.
Non-physiological primary: Percent days abstinent, drinks per drinking day, drinking
consequences,
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization to treatment was per-
formed using a computerized urn balanc-
ing program designed to minimize differ-
ences on critical demographic and match-
ing variables”.
Allocation concealment (selection bias) Unclear risk Randomization process centrally con-
trolled by the coordination centre.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were
physiological and also used to validate self-
reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk No blinding, but most outcomes were
physiological and also used to validate self-
reports, and not likely to be influenced by
lack of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition was less than 10% at the 3, 6, 9,
12, and 15 months follow-ups in the after-
care and outpatient groups. Balanced. Rea-
sons for 3-year attrition in the outpatient
group given. The authors state that all ran-
domised participants are included in the
analyses, but in a results table they included
only data for subjects who had non missing
values at all three time points.
Selective reporting (reporting bias) Unclear risk Primary outcomes measures (PDA and
DDD) reported incompletely (only by
graphs). Outcome for drinking conse-
quences only reported in tables for 9- and
15 months follow-up.
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MATCH 1993 (Continued)
Other bias Low risk Collateral report, laboratory tests (blood
and urine) as check on self-report. Breath-
alyzer at each assessment point. Inclusion
criteria contained no planned involvement
for additional treatment during the study
period. There were no differences between
groups at baseline. No additional sources
of bias appear to be present.
McCambridge 2008
Methods RCT.
Participants 326 young cannabis users aged 16-19 years not seeking help from eleven London Further
Education colleges. UK.
Interventions Single session intervention of MI (n= 164) vs drug information and advice giving (n=
162).
Outcomes Physiological primary: None (but bogus pipeline).
Non-physiological primary: 30-day frequency of cannabis use (joints past week), 30-
day alcohol consumption (units of alcohol past week + AUDIT score).
Secondary: None.
Follow-ups were at 3 and 6 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Computerised individual randomisationwas undertakenby the
local clinical trials unit.”
Allocation concealment (selection bias) Low risk “Decisions were communicated on an individual basis via tele-
phone or e-mail to researchers after recruitment and baseline
data collection to preserve allocation concealment.”
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but bogus pipeline.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Study participants self-completed questionnaires which were
distributed by a researcher who was blind to study allocation.”
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McCambridge 2008 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 17% and 19% lost to follow-up at 3 and 6 months, respec-
tively. Unequal between groups. Reasons for loss-to-follow-up
not stated. Intention to treat using last observation carried for-
ward.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Low risk A bogus pipeline approach was used in addition to self-report.
There were no differences between groups at baseline. No addi-
tional sources of bias appears to be present.
Miller 2003
Methods Multisite RCT (2 sites).
Participants 208 US outpatients and inpatients entering public agencies for treatment of drug prob-
lems.
Interventions 1 session MI (n= 104) vs treatment as usual (n= 104).
Outcomes Physiological primary: Urine toxicology.
Non-physiological primary: Percent days abstinent from illicit drugs and alcohol.
Secondary: Retention (frequency of therapy sessions attended).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn randomisation.
Allocation concealment (selection bias) Unclear risk The urn randomisation was performed while the client was
completing baseline assessment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but urine toxicology.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Assessment for all participantswas conducted by experienced
interviewing staff of CASAA’s Program Evaluation Services
unit, who were unaware of treatment group assignment.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk At 3, 6, 9, and 12 months, attrition was 7%, 14%, 20% and
21%, respectively. Loss was balanced across groups. Reasons
not reported. ITT not performed.
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Miller 2003 (Continued)
Selective reporting (reporting bias) Unclear risk AddictionSeverity Indexwas reported in themethods section,
but it was not reported in the results section.
Other bias Unclear risk Urine drug screens and collateral reports were used to check
on self-report. There is a possibility that the standard care
grouphad receivedMI.TheMIgroup received one additional
session. There were no differences between groups at baseline.
Morgenstern 2009
Methods RCT.
Participants 150 non-treatment-seeking men who have sex with men. USA.
Interventions 4 sessions of MI (n= 70) vs a 4-session educational control condition (n= 80).
Outcomes Physiological primary: None.
Non-physiological primary: Days of any club drug use (Timeline Followback).
Secondary: None.
Follow-ups were at 3, 6, 9, and 12 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used an urn randomisation procedure.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely to be
influenced by lack of blinding due to validation with physiolog-
ical measurement.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Insufficient information to tell if assessor was blinded, but the
outcome measurements are not likely to be influenced by lack
of blinding due to validation with physiological measurement.
Incomplete outcome data (attrition bias)
All outcomes
High risk 23% attrition at 12 months. Not different between conditions.
No reasons stated. No ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
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Morgenstern 2009 (Continued)
Other bias Unclear risk Self-report was confirmed by urine toxicology testing. There was
more marijuana use in the treatment group at baseline.
Naar-King 2007
Methods RCT.
Participants 65 youth (ages 16-25 years) living with HIV. USA.
Interventions MET(n= 32) vs wait list (n= 33).
Outcomes Physiological primary: None.
Non-physiological primary: Number of standard drinks in one week and number of
times used marijuana in one week (via Timeline Follow-Back).
Secondary: None.
Follow-ups were at baseline, 3, and 6 months.
Notes The intervention is known as “Healthy Choices”.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random numbers were generated by the project manager using
an Internet based random number generator and were placed in
sealed envelopes.”
Allocation concealment (selection bias) Low risk “The data collector received sealed envelopes revealing randomi-
sation status, which were opened after the baseline assessment so
that the intervention sessions could be scheduled immediately
for the treatment group.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition at 6months was 23% for the whole sample. No reasons
stated. Balanced. ITT conducted.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
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Naar-King 2007 (Continued)
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not reported.
Parsons 2009
Methods RCT.
Participants 143 HIV-positive men and women who were on antiretroviral medication and met
criteria for hazardous drinking. USA.
Interventions MI + cognitive-behavioral skills building (n= 65) vs a time- and content-equivalent
educational condition (n= 78).
Outcomes Physiological primary: None.
Non-physiological primary: Standard drinks in the past and drinks per drinking day.
Secondary: Medication adherence.
Follow-up at baseline and at 3- and 6-month follow-ups.
Notes Intervention is known as Project PLUS (Positive Living Through Understanding and
Support).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Urn randomisation procedures were used.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk “An intent-to-treat analysis was used in which participants who
completed the first follow-up assessments were analyzed accord-
ing to their original assigned study condition irrespective of the
number of sessions attended.” Attrition was 9% at the 3-month
follow-up and 10% at the 6-month follow-up with no signifi-
cant difference in attrition between the 2 conditions. Reasons
for attrition provided.
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Parsons 2009 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the stated hypotheses.
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not reported.
Peterson 2006
Methods RCT.
Participants 285 US homeless adolescents recruited from drop-in centres and from street intercept.
Interventions 1. Brief ME (n= 92)
2. assessment at follow-up (n= 94)
3. assessment only (n= 99).
Outcomes Physiological primary: None.
Non-physiological primary: Marijuana drug use days, other illicit drug use days.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...a two-step urn randomizations on gender and ethnicity.”
Allocation concealment (selection bias) Unclear risk Randomization at central location.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely to be
influenced by lack of blinding due to validation with physiolog-
ical measurement.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk “Follow-up interviewers... were not blind to condition.” The
outcome measurements are not likely to be influenced by lack
of blinding due to validation with physiological measurement.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 18%and 20%attrition at 1 and 3month follow-up, respectively.
Balanced. Reasons for loss to-follow-up not stated. Use of ITT
was stated by the authors but not reported.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
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Peterson 2006 (Continued)
Other bias Low risk Urine samples collected at 3 month follow-up. There were no
differences between groups at baseline. No additional sources of
bias appear to be present.
Rohsenow 2004
Methods RCT.
Participants 165 US cocaine dependent patients.
Interventions 1. MET followed by group coping skills (n= 44)
2. MET followed by drug education (n= 39)
3. meditation relaxation followed by group coping skills (n= 44)
4. mediation relaxation followed by drug education (n= 38).
Outcomes Physiological primary: None.
Non-physiological primary: Number of cocaine use days, percentage of days alcohol
used.
Secondary: Readiness to change (Cocaine Change Assessment Questionnaire). Data not
reported.
Retention in treatment (days treated in partial hospital [data not reported]).
Notes Results data are not available. Mail from Dr. Rohsenow May 19th 2010.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Stratified randomisation balanced gender and cocaine use fre-
quency.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely to be
influenced by lack of blinding due to validation with physiolog-
ical measurement.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Research assistants blind to treatment condition conducted as-
sessments.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 10% attrition at 12 months follow-up. We do not know the at-
trition at 3 and 6 months. Reasons for attrition unclear. Unclear
if attrition was balanced across groups. Use of ITT was reported,
but analyses were not reported with the full sample.
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Rohsenow 2004 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Urine drug screens and collateral reports to check on self-report.
The MET group reported drinking on more days at baseline.
Saitz 2007
Methods RCT.
Participants 341 US medical inpatients who were drinking risky amounts of alcohol.
Interventions Motivational counselling (n= 172) vs usual care (n= 169).
Outcomes Physiological primary: None.
Non-physiological primary: Drinking risky amounts, heavy drinking episodes, absti-
nence.
Secondary: Readiness to change (Taking Steps Scale on the Stages of Change Readiness
and Treatment Eagerness Scale). Data not reported.
Received alcohol assistance.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”...permuted block (size 8) randomisation procedure stratified
by AUDIT score.“
Allocation concealment (selection bias) Unclear risk Used sealed opaque envelopes. It is unclear whether the en-
velopes were opaque and/or sequentially numbered.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk At 3 months follow-up, the attrition was 17% in the usual care
group and 24% in the brief intervention group. At 12 months,
the attrition was 14% in the usual care group and 18% in the
brief intervention group. Flow chart with reasons for attrition
reported. It appears that ITT was performed (”...analyzed all
patients in the groups to which they were randomly assigned.)
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Saitz 2007 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Baseline imbalances (gender, alcohol-attributable medical diag-
noses, received alcohol assistance, drug use) existed despite ran-
domization. Biological breath tests were conducted at follow-
ups.
Schaus 2009
Methods RCT.
Participants 363 college students who screened positive for high-risk drinking. USA.
Interventions MI + a brochure (n = 181) vs a control group receiving only the brochure (n = 182).
Outcomes Physiological primary: None.
Non-physiological primary: Typical BAC, peak BAC, average number of drinks per
sitting, number of days with heavy episodic drinking, peak number of drinks in one
sitting, average number of drinks per week, and number of times drunk in a typical
week.
Secondary: Readiness to change (Readiness to Change Questionnaire).
Follow-ups were at 3, 6, 9, and 12 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were block randomised using SPSS Version 15.0 ...to
either the control or intervention group, where the order of the
interventions varied randomly within each block.”
Allocation concealment (selection bias) Unclear risk “The group assignment was placed into a sealed envelope by the
data manager and was not available to those recruiting subjects
until after informed consent was obtained.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
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Schaus 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Percent lost to follow-up after 3, 6, 9, and 12 months were 24%,
42%, 41%, and 35%, respectively. Follow-up did not differ sig-
nificantly between groups. Reasons for attrition not provided.
ITT probably performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias High risk Only self-reported outcomes. The variable “number of
times drove after≥3 drinks.” was higher in the control group at
baseline.
Sellman 2001
Methods RCT.
Participants 125 patients from New Zealand with mild to moderate alcohol dependence.
Interventions 1. MET (n= 42)
2. non-directive reflective listening (n= 40)
3. no further counselling (n= 40).
Outcomes Physiological primary: None.
Non-physiological primary: Broke abstinence, exceeded national guidelines at least
once, exceeded national guidelines six or more times, drank 10+ standard drinks at least
once, drank 10+ standard drink six or more times.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomly constructed list of therapies.”
Allocation concealment (selection bias) Low risk “An administrative person who was independent of the assess-
ment and treatment of the study was contacted regarding the
therapy to be undertaken.”
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Low risk “A senior research assistant, who was blind to the treatment
received, successfully completed follow-up.”
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Sellman 2001 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% attrition at 6 months follow-up. Attrition was balanced
across conditions, but no reasons were reported. It is unclear
whether ITT was performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Collateral to check on self-report. There were differences be-
tween groups at baseline for GAS score. No additional sources
of bias appear to be present.
Stein 2002
Methods RCT.
Participants 187 US AUDIT-positive active injection drug users.
Interventions MI (n= 95) vs control (assessment only) (n= 92).
Outcomes Physiological primary: None.
Non-physiological primary: Number of drinking days.
Secondary: None.
Notes BRAINE study.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were assigned to treatments using a randomisation
schedule created with permuted blocks of eight assignments.”
Allocation concealment (selection bias) Unclear risk “The data manager prepared the randomisation schedule before
the first patient enrolled.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “At each follow-up assessment, research assistants were blinded
to the treatment condition of the subject.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3% loss to follow-up at 6 months. Balanced. No reasons pro-
vided. ITTperformed.Missing datawere imputed using a ’worst
case scenario’ strategy.
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Stein 2002 (Continued)
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. There were no differences between
groups at baseline.
Stein 2009
Methods RCT.
Participants 198 persons who used cocaine at least weekly and who were not in treatment. USA.
Interventions 4-session motivational intervention (n= 97) or an assessment only control group (n=
101). Both groups received a written handout list of treatment resources. Each session
lasted 20 to 40 minutes.
Outcomes Physiological primary: None.
Non-physiological primary: Any reduction in cocaine use, more than 50% reduction,
and abstinence.
Secondary: Treatment attendance (inpatient therapy, attended NA or CA, any drug
treatment).
Follow-up at 6 months.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization and concealment were overseen by the study
methodologist.”
Allocation concealment (selection bias) Unclear risk “Randomization and concealment were overseen by the study
methodologist.”
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Follow-up interviews were performed by research staff blinded
to study conditions.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT performed. Attrition was 19% at 6 months. Reasons not
stated.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
86Motivational interviewing for substance abuse (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Stein 2009 (Continued)
Other bias Unclear risk Only self-reported outcomes. There were no differences between
groups at baseline.
Stein 2010
Methods RCT.
Participants 245 incarcerated women with hazardous drinking.
Interventions MI (n= 125) vs assessment only (n= 120).
Outcomes 90-day drinking (probability of an abstinent day, drinks per drinking day) using Timeline
Followback at 1, 3 and 6 months follow-up.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization and concealment were overseen by the study
methodologist (B.J.A.)”.
Allocation concealment (selection bias) Unclear risk “Randomization and concealment were overseen by the study
methodologist (B.J.A.)”.
Blinding (performance bias and detection
bias)
Patients and providers
High risk Patients and providers were not blinded to the interventions.
Blinding (performance bias and detection
bias)
Assessors
Low risk “...research staff performing the assessments were blinded to the
participant’s assigned
condition.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition was 24% at 1 month, 21% at 3 months and 21% at 6
months. Balanced. Not ITT. No reasons.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. There were no differences between
groups at baseline.
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Stephens 2007
Methods RCT.
Participants 188 US marijuana users.
Interventions 1. Personalized feedback (utilising MI) (n= 62)
2. educational control (multi-media feedback) (n= 62)
3. delayed feedback (n= 64).
Outcomes Physiological primary: None.
Non-physiological primary: Days of marijuana use per week, periods smoked per day,
dependence symptoms.
Secondary: Motivation (Readiness to Change Questionnaire). Data not reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used an urn randomisation program.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk No blinding but the outcome measurements are not likely to be
influenced by lack of blinding due to validation with physiolog-
ical measurement.
Blinding (performance bias and detection
bias)
Assessors
Low risk “...research staff...was not aware of assigned condition”.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition was 5% at 7 weeks, 10% at 6 months, and 19% at 12
months follow-up. Balanced across conditions. No reasons. ITT
probably performed (missing data were replaced with baseline
values).
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Urine specimens were collected at each assessment point and
analysed for the presence of drug metabolites via enzyme im-
munoassay tests. Differences between groups at baseline were
not reported. No additional sources of bias appear to be present.
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Stotts 2001
Methods RCT.
Participants 105 US cocaine-dependent men and women aged 18-50 years admitted to a university
medical centre.
Interventions MI vs detox-only. The group sizes were not reported. The detox only conditions was
“...a multi component intervention consisting of daily visits, interaction with research
assistants, education, and graphing and feedback of daily urine results, as well as bonus
money and further treatment contingent on successful completion of the program.”
Outcomes Physiological primary: Cocaine-positive urine samples.
Non-physiological primary: Cocaine use.
Secondary: Treatment retention (completion of detox program).
Readiness to change (Processes of Change Scale).
Notes We sent an email on April 29th 2010 requesting the group sizes. On June 4th we
contacted Brad Lundahl, author of a systematic review for effect size information. He
gave us effect size data.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomly assigned...”
Allocation concealment (selection bias) Unclear risk “...randomly assigned...”
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used to
validate self-reports, and not likely to be influenced by lack of
blinding.
Incomplete outcome data (attrition bias)
All outcomes
High risk Intention to treat of the full sample (N =105) were conducted on
completion of the DP. The number of participants randomised
to each condition is not reported. Analysis of urine samples were
conducted on 51 completers.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Urineanalysis to validate self-report. There were no differences
between groups at baseline. No additional sources of bias appear
to be present.
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Stotts 2006
Methods Pilot RCT.
Participants 31 male treatment-seeking cocaine abusers. USA.
Interventions Two-session MI intervention with informative biological EEG/ERP feedback (n=17) or
a minimal control condition who had two brief meetings with an experienced research
assistant weekly over two weeks (n=14).
Outcomes Physiological primary: Cocaine-positive urine screens.
Non-physiological primary: Proportion of self-reported cocaine use days.
Secondary: Readiness to change (URICA). Data not reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomised”.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced by
lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Posttreatment assessment was conducted at 1-week post-study
by clinic staff blind to study condition.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only subjects with data at both time points were analysed (27/
31 = 13% attrition). Reasons for missing data not reported. ITT
not performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk EEG screening to validate self-report. There were no differences
between groups at baseline. No additional sources of bias appear
to be present.
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Thush 2009
Methods RCT.
Participants 125 Dutch at-risk adolescents.
Interventions MI plus information flyers (n=61) vs information flyers only (n=64).
Outcomes Physiological primary: None.
Non-physiological primary: Alcohol use.
Secondary: Readiness to change using a readiness-to-change ruler. Data not reported.
Follow-ups at 1 month and 6 months.
Notes Email sent to Thush requesting raw outcome data on May 28th 2010. Thush replied
immediately promising to look into it. They have computed a log transformed standard-
ized alcohol use index score out of six different correlated alcohol use outcome measures.
A reminder was sent on August 30th. An out of office reply informed that Thush had
resigned.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly assigned”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk 10% lost to follow-up at 1 month and 41% lost to follow-up
at 6 months. Reasons not provided. Balanced at 1 month. Not
known whether loss was balanced at 6 months. Not ITT.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. Differences between groups at
baseline were not reported.
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UKATT 2005
Methods Multisite RCT (7 sites).
Participants 742 UK clients with alcohol problems.
Interventions MET(n= 442) vs social behavior and network therapy (n= 320).
Outcomes Physiological primary: Gamma-glutamyl transferase
Non-physiological primary:Days abstinent, number of drinks per drinking day, Leeds
Dependence Questionnaire score, alcohol problems score.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The remote randomisation service at York used a computer
”on line“ to allocate consenting participants between therapy
groups.”
Allocation concealment (selection bias) Unclear risk “Treatment was concealed until allocation.”
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Assessors blinded at 12months but not at 3months. Butmost
outcomes were physiological and also used to validate self-
reports, and not likely to be influenced by lack of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7% attrition at 3 months follow-up and 17% attrition at 12
months follow-up. Balanced. Reasons provided. ITT using
last observation carried forward performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
Other bias Low risk Gamma GT used to check on self-report. There were no
differences between groups at baseline. No additional sources
of bias appear to be present.
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Walitzer 2008
Methods RCT.
Participants 169 alcoholic outpatients. USA.
Interventions (1) a motivational approach to facilitating AA (n=58), (2) a 12-step directive approach
to facilitating AA (n=53), or (3) treatment as usual with no special emphasis on AA (n=
58). All conditions received 12 sessions.
Outcomes Physiological primary: None.
Non-physiological primary: Percentage of days abstinent, percentage of days heavy
drinking via the Timeline Followback.
Secondary: Attendance at AA meetings.
Notes On 11 October 2010 we sent an email to Kim Walitzer (walitzer@ria.buffalo.edu) re-
questing data on retention in treatment.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random assignment to conditions was conducted by the third
author via urn randomisation...”.
Allocation concealment (selection bias) Unclear risk “Random assignment to conditions was conducted by the third
author via urn randomisation...”. Insufficient information to
permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
Unclear risk Blinding of providers was not possible, but participants could
have been blinded.
Blinding (performance bias and detection
bias)
Assessors
Low risk “Research interviewers were blind to intervention condition.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 10% attrition on interview and 15% on questionnaire data. No
reasons stated. Similar across conditions. Not ITT in primary
analysis.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Low risk Used collateral interviews to check on self-report. Differences
between groups at baseline were not reported. No additional
sources of bias appear to be present.
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Walker 2006
Methods Multisite RCT (4 sites).
Participants 97 US adolescents.
Interventions 2 session MET (n= 47) vs 3 months delayed condition (n= 50).
Outcomes Physiological primary: None.
Non-physiological primary: Number of days of marijuana use.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomly assigned.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk “Baseline and 3-month follow-up assessments were admin-
istered by an audio-computer-assisted self-interviewing pro-
gram.” But “a different HE (health educator) was assigned to
conduct the follow-up.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition was 5% overall at 3 months follow-up (9% in the
MET group and 2% in the DFC group). Unbalanced across
conditions. Reasons not reported. Stated use of ITT but re-
ported only actual data.
Selective reporting (reporting bias) High risk Authors stated alcohol and other drugs as outcomes but re-
ported only marijuana use in the results. Some results were
only claimed as “not significant” but not reported explicitly.
Other bias Unclear risk Only self-reported outcomes. There were more whites in the
immediate treatment group than in the delayed treatment
group at baseline.
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Walters 2009
Methods Dismantling RCT.
Participants 279 heavy drinking college students. USA.
Interventions (1) A single MI session without feedback (MIO, n=70), (2) a single MI session with
feedback (MIF, n=73), (3) web feedback only (FBO, n=67), or (4) assessment only (AO,
n=69).
Outcomes Physiological primary: None.
Non-physiological primary: Drinks per week, estimated peak BAC.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization, stratified by sex and heavy-drinking frequency
(i.e., one heavy episode in the past 2 weeks vs. more than one
heavy episode), was completed automatically after the students
entered their screening data.”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 10% attrition at 3 months and 14% attrition at 6 months. Dif-
ferent across groups. No reasons. ITT not conducted.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias Unclear risk The feedback format varied (i. e. online vs. face-to-face) and
MIO and MIF conditions varied in contact time because of the
feedback component. There were no differences between groups
at baseline.
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White 2006
Methods RCT.
Participants 222 mandated college students. USA.
Interventions Brief motivational interview (n = 180) vs written feedback only (n = 168).
Outcomes Physiological primary: None.
Non-physiological primary: Past month alcohol frequency, number of occasions of
heavy episodic drinking, number of drinks and number of hours of drinking each day
in a typical week in the last month. Frequency of marijuana use in the past month.
Secondary: None.
Follow-up at 3 months post-intervention.
Notes White 2007 is the same study with further recruitment (n=348). The follow-ups were
at 4 and 15 months.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly assigned by the flip of a coin.
Allocation concealment (selection bias) Low risk Randomly assigned by the flip of a coin.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5% lost to follow-up. Reasons not stated. Balanced. ITT not
conducted.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias High risk Only self-report but included the Social Desirability Scale. Par-
ticipants in the BMI group were in an earlier college year and
had higher RAPI scores than participants in the written feedback
group at baseline.
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Winhusen 2008
Methods Multisite RCT (4 sites).
Participants 200 US pregnant substance users.
Interventions 3 session MET (n= 102) vs treatment as usual (n= 98).
Outcomes Physiological primary: Urine toxicology
Non-physiological primary: Days of use alcohol/drugs.
Secondary: Readiness to change (URICA).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used urn randomisation.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
Low risk No blinding, but most outcomes were physiological and also
used to validate self-reports, and not likely to be influenced
by lack of blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk Insufficient information to know whether assessors were
blinded. But most outcomes were physiological and also used
to validate self-reports, and not likely to be influenced by lack
of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 14% attrition at 1 month follow-up and 20% attrition at
3 months. Balanced. Reasons for dropout stated. ITT was
performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based
on the study hypotheses.
Other bias Unclear risk Urine samples were collected and tested for opiates, co-
caine, methamphetamines, benzodiazepines, and marijuana
at screening, weekly during the active phase of the study
phase, and at the two follow-up visits. The MET group used
more cocaine and the TAU group used more marijuana at
baseline. There were also baseline differences in age, ethnic-
ity, education and pressure to attend treatment.
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Winters 2007
Methods RCT.
Participants Students (n = 53) identified in a school setting as drug abusers. USA.
Interventions 2 sessions of MI with the adolescent only (n=26) vs assessment only control (n=27).
Outcomes Physiological primary: None.
Non-physiological primary:Number of alcohol use days, number of binge days, num-
ber of illicit drug use days.
Secondary: Additional treatment.
Follow-up at 6 months.
Notes There was also a third group that received 2 sessions with the adolescent and one with the
parent (n=26). This group did not meet our inclusion criteria. 1 student in the control
group dropped out, so each group in the analyses contain 26 students.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomly assigned...”
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Low risk “An experienced research assistant, who was blind to treatment
condition, completed the intake, 1-month, and 6-months fol-
low-up interviews.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% attrition at 6 months follow-up.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes based on
the study hypotheses.
Other bias High risk “During the 6-months TSR interview, those in the BI-AP condi-
tion reported more additional treatment (27%) compared with
those in the BI-A condition (16%)”. Only self-report. There
were no differences between groups at baseline.
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Wood 2007
Methods RCT (2x2 factorial design).
Participants 335 US heavy drinking college students.
Interventions 1. Brief MI (BMI) (n= 84)
2. Alcohol Expectancy Challenge (AEC) (n= 87)
3. BMI and AEC (n= 81)
assessment only (n= 83).
AEC involved 2 sessionswith a groupdiscussion about alcohol expectancies in a simulated
bar environment.
Outcomes Physiological primary: None.
Non-physiological primary: Number of drinks per week, number of heavy drinking
episodes in the past 30 days. Hangovers, blackouts, increased subjective tolerance.
Secondary: None.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”...randomized, separately by gender.“
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment.
Blinding (performance bias and detection
bias)
Patients and providers
High risk No blinding.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk It is not stated whether the assessors were blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk ”Cumulative participant attrition was 18%, 25%, and
28% at 1-, 3-, and 6 month follow-ups, respectively. Not
balanced. 21 in the AEC group and 24 in the BMI-AEC
group were dropped by design because it was not possi-
ble to schedule them for at least one of two group AEC
sessions. ITT was not performed.
Selective reporting (reporting bias) Low risk The published report included all expected outcomes
based on the study hypotheses.
Other bias Unclear risk Only self-reported outcomes. There were no differences
between groups at baseline.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adamson 2001 Substance abuse was not an outcome.
Allsop 1997 Group MI.
Anderson 1992 Intervention was not MI.
Aubrey 1998 Not fidelity check using video or audio.
Baer 2001 Not fidelity check using video or audio.
Baker 1993 Substance abuse was not an outcome.
Baker 2001 Not fidelity check using video or audio.
Baker 2002 Not fidelity check using video or audio.
Baker 2002b Substance abuse was not an outcome.
Baker 2005 Not fidelity check using video or audio.
Baker 2006 Not fidelity check using video or audio.
Barrowclough 2000 No results reported. Ongoing study in 2000.
Barrowclough 2001 Not individual face-to-face intervention.
Becka 2004 Not a randomized controlled trial.
Beckham 2007 Not fidelity check using video or audio.
Bellack 2006 Intervention was not MI.
Bernstein 2005 Not fidelity check using video or audio.
Bethea 2006 Intervention was not MI.
Booth 1998 Substance abuse was not an outcome.
Borsari 2000 Not fidelity check using video or audio.
Borsari 2003 Intervention was not MI.
Brown 1993 Not a randomized controlled trial.
Brown 2007 Not individual face-to-face intervention. (Telephone and mail intervention).
100Motivational interviewing for substance abuse (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Brown 2009 Not fidelity check using video or audio.
Butler 2009 Not fidelity check using video or audio.
Bux 2005 Intervention was not MI.
Ceperich 2002 No data reported.
Chapman 2009 Not individual face-to-face intervention.
Chavez 2003 Substance abuse was not an outcome.
Clinton-Sherrod 2008 Substance abuse was not an outcome.
Corrigan 2005 Substance use was not an outcome.
D’Angelo 2005 Not fidelity check using video or audio.
Daeppen 2007 Not MI
Daley 1998 Substance use was not an outcome.
Davidson 2007 Did not compare MI with alternative. Both conditions received MI.
Davis 2003 Not fidelity check using video or audio.
Demmel 2003 Not a randomized controlled trial.
Dench 2000 Substance abuse was not an outcome.
Dent 2008 Not fidelity check using video or audio. Main references to Miller and Rollnick are missing.
Dermen 2000 Not MI
Disney 2005 Substance abuse was not an outcome.
Dunn 1997 Not a randomised controlled trial.
Dunn 2004 Substance abuse was not an outcome.
Easton 2000 Substance abuse was not an outcome.
Edwards 2006 Not fidelity check using video or audio.
Fergusin 1998 Not MI.
Floyd 2007 Not fidelity check using video or audio.
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Gauthier-Faille 2006 Not MI.
Gentilello 2001 Substance abuse was not an outcome (outcomes were injuries and traumas.)
Ginsburg 2001 Substance abuse was not an outcome.
Godley 2010 Not individual face-to-face intervention. (Part of the intervention involved the family.)
Gogineni 2005 Not MI.
Goti 2010 Not fidelity check using video or audio.
Gray 2005 Not a randomized controlled trial.
Gregory 2001 Not MI. Not substance abusers.
Gwadz 2008 Not MI.
Handmaker 1999 Not substance abusers.
Harper 2000 Not a randomized controlled trial.
Haug 2004 Substance abuse was not an outcome.
Hayes 2007 Not substance abusers.
Heather 1996 Not a randomized controlled trial.
Hester 2005 Not individual face-to-face intervention.
Hickman 1999 Not fidelity check using video or audio.
Hicks 1999 Not fidelity check using video or audio.
Holder 2000 Not a randomized controlled trial.
Hulse 2003 Substance abuse was not an outcome.
Johnson 2006 Intervention was not MI.
Juarez 2006 Not substance abusers.
Jungerman 2007 Not fidelity check using video or audio.
Kanouse 2005 Not a randomized controlled trial.
Kidorf 2005 Substance abuse was not an outcome.
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Kidorf 2009 Not fidelity check using video or audio.
Kinlock 2005 Substance abuse was not an outcome.
Kuchipudi 1990 Not fidelity check using video or audio.
Lachance 2004 Not MI.
Larimer 2001 Not substance abusers.
Longabaugh 2001 Not substance abusers.
Longabaugh 2009 Not fidelity check using video or audio.
Lozano 2006 Intervention was not MI.
Magill 2009 Not fidelity check using video or audio.
Mahmood 2002 Substance abuse was not an outcome.
Marlatt 1998 Not fidelity check using video or audio.
Martino 2000 Not fidelity check using video or audio.
Mausbach 2007 Substance abuse was not an outcome.
McCambridge 2004 Not fidelity check using video or audio.
McDowell 2006 Intervention was not MI.
Mckee 2007 Not fidelity check using video or audio.
McNally 2005 Not fidelity check using video or audio.
Michael 2006 Not individual face-to-face intervention.
Miller 2005 Not a randomized controlled trial.
Mitcheson 2007 Not MI.
Monti 1999 Not substance abusers.
Monti 2007 Not substance abusers.
Morgenstern 2007 Did not compare MI with alternative intervention.
Mullins 2004 Substance abuse was not an outcome.
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Murphy 2001 Does not compare MI with alternative intervention.
Murphy 2003 Not MI.
Murphy 2004 Not fidelity check using video or audio.
Noonan 2001 Not individual face-to-face intervention (Group MI.)
Oliveira 2008 Not fidelity check using video or audio.
Ondersma 2007 Not individual face-to-face intervention. (Computer-delivered.)
Parsons 2007 Not fidelity check using video or audio.
Patterson 2008 Not a randomized controlled trial.
Pavone 2002 Not a randomized controlled trial.
Rao 1999 Not individual face-to-face intervention.
Reid 2005 Not MI.
Rimmele 1998 Not a randomized controlled trial.
Samet 2005 Substance abuse was not an outcome.
Sanchez 2001 Not MI.
Sanchez-Craig 1996 Not fidelity check using video or audio.
Santa Ana 2005 Not MI.
Santa Ana 2007 Not individual face-to-face intervention. (Group MI.)
Saunders 1995 Not fidelity check using video or audio.
Schilling 2002 Not a randomized controlled trial.
Scott 2002 Substance abuse was not an outcome.
Scott 2009 Not MI.
Sears 2006 Substance abuse was not an outcome.
Sinha 2003 Not fidelity check using video or audio.
Sitharthan 1999 Not a randomized controlled trial.
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Sobell 2002 Not individual face to face intervention.
Soderstrom 2007 Not substance abusers.
Stein 2002a Not a randomized controlled trial.
Stein 2006 Substance abuse was not an outcome.
Stein 2006a Substance abuse was not an outcome.
Stephens 2000 Not fidelity check using video or audio.
Stephens 2002 Not a randomized controlled trial.
Stockwell 1986 Not a randomized controlled trial.
Stotts 2004 Not MI.
Swanson 1999 Substance abuse was not an outcome.
Tapert 2003 Not substance abusers.
Tevyaw 2007 Not individual face-to-face intervention.
Thevos 1998 Not a randomized controlled trial.
Thush 2007 Not fidelity check using video or audio.
Tirado 2005 Not MI.
Vanderburg 2003 Substance abuse was not an outcome.
Velasquez 2009 Not individual face-to-face intervention. (Both individual and group MI.)
Wain 2006 Substance abuse was not an outcome.
Walters 2000 Intervention was not MI.
Walton 2010 Intervention is opportunistic one-session MI in emergeny room.
Weinrieb 2005 Not MI.
Wells 1998 Not a randomized controlled trial.
Wells 2004 Not MI.
Wertz 1994 Not fidelity check using video or audio.
Whitten 2006 Substance abuse was not an outcome.
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Wilbourne 2005 Not a randomized controlled trial.
Woodall 2007 Not fidelity check using video or audio.
Woody 2001 Not MI.
Yonkers 2009 Not a randomized controlled trial.
Zahradnik 2009 Not acceptable drug (prescription drugs).
Zule 2009 Not fidelity check using video or audio.
Characteristics of studies awaiting assessment [ordered by study ID]
Barrowclough 2010
Methods RCT.
Participants Patients with psychosis and substance abuse.
Interventions Integrated MI and CBT treatment vs standard psychiatric care.
Outcomes Frequency of substance abuse.
Notes
Walters 2010
Methods Randomized effectiveness trial.
Participants 380 probationers.
Interventions MI vs waiting list control.
Outcomes Probability of having a drug-positive urinalysis or an otherwise poor outcome after 6 months.
Notes Study was located while preparing to submit the review.
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Characteristics of ongoing studies [ordered by study ID]
Dubertret 2010
Trial name or title Effect of motivational therapy on schizophrenia with cannabis misuse.
Methods RCT.
Participants Schizophrenia or schizo-affective disorder according to DSM-IV criteria.
Interventions MI vs usual care.
Outcomes Cannabis consumption evaluated by the Time-Line Follow Back at 6 months inclusion, 3 month, 6 month,
12 month.
Starting date November 2008.
Contact information Caroline Dubertret (caroline.dubertret@lmr.aphp.fr)
Assistance Publique - Hopitaux de Paris.
Telephone: +33 (0) 14760 6413
Notes
Forsberg 2010
Trial name or title Effects of Motivational Interviewing in Prison.
Methods RCT.
Participants Alcohol abusers.
Interventions MI vs usual planning interview routine.
Outcomes Number of days with substance use of the last 30 days. Alcohol- or drug use as measured by the Addiction
Severity Index (ASI) at intake and at 10 months after release.
Starting date April 2004.
Contact information Lars G Forsberg
Karolinska Institutet, Dep Clin. Neuroscience, Stockholm, Sweden.
Notes
107Motivational interviewing for substance abuse (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hansen 2010
Trial name or title Brief intervention for heavy drinkers.
Methods RCT.
Participants Alcohol abusers.
Interventions MI vs leaflets about alcohol.
Outcomes Reduction of 25% in self reported alcohol consumption.
Starting date January 2008.
Contact information Anders B. Gottlieb Hansen
University of Southern Denmark, National Institute of Public Health.
Notes
Morken 2010
Trial name or title Motivational interviewing to acutely admitted psychiatric patients with comorbid substance use
Methods Single-blind RCT.
Participants Adult patients with substance use acutely admitted to psychiatric
hospital.
Interventions MI vs standard treatment.
Outcomes Substance use and function questionnaire.
Admissions to hospital.
Number of contacts with primary health care.
Starting date October 2004.
Contact information Gunnar Morken (gunnar.morken@ntnu.no)
Norwegian University of Science and Technology.
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. MI versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Extent of substance use 25 Std. Mean Difference (Random, 95% CI) Subtotals only
1.1 Post-intervention 4 202 Std. Mean Difference (Random, 95% CI) 0.79 [0.48, 1.09]
1.2 Short f-u 15 2327 Std. Mean Difference (Random, 95% CI) 0.17 [0.09, 0.26]
1.3 Medium f-u 12 2326 Std. Mean Difference (Random, 95% CI) 0.15 [0.04, 0.25]
1.4 Long follow-up 1 363 Std. Mean Difference (Random, 95% CI) 0.06 [-0.16, 0.28]
2 Readiness to change 5 1495 Std. Mean Difference (Random, 95% CI) 0.05 [-0.11, 0.22]
3 Retention in treatment 2 427 Std. Mean Difference (Random, 95% CI) 0.26 [-0.00, 0.52]
Comparison 2. MI versus treatment as usual
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Extent of substance use 11 Std. Mean Difference (Random, 95% CI) Subtotals only
1.1 Post-intervention 9 1940 Std. Mean Difference (Random, 95% CI) 0.01 [-0.09, 0.11]
1.2 Short f-u 10 2102 Std. Mean Difference (Random, 95% CI) 0.01 [-0.08, 0.10]
1.3 Medium f-u 5 890 Std. Mean Difference (Random, 95% CI) 0.08 [-0.05, 0.21]
2 Retention in treatment 4 1354 Std. Mean Difference (Random, 95% CI) -0.11 [-0.41, 0.19]
Comparison 3. MI versus assessment and feedback
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Extent of substance use 7 Std. Mean Difference (Random, 95% CI) Subtotals only
1.1 Short f-u 7 986 Std. Mean Difference (Random, 95% CI) 0.12 [-0.01, 0.24]
1.2 Medium f-u 2 265 Std. Mean Difference (Random, 95% CI) 0.38 [0.10, 0.66]
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Comparison 4. MI versus other active intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Extent of substance use 14 Std. Mean Difference (Random, 95% CI) Subtotals only
1.1 Post-intervention 2 185 Std. Mean Difference (Random, 95% CI) -0.07 [-0.37, 0.23]
1.2 Short f-u 12 2137 Std. Mean Difference (Random, 95% CI) 0.02 [-0.07, 0.12]
1.3 Medium f-u 6 1586 Std. Mean Difference (Random, 95% CI) -0.02 [-0.16, 0.13]
1.4 Long f-u 2 437 Std. Mean Difference (Random, 95% CI) -0.03 [-0.21, 0.14]
2 Readiness to change 2 350 Std. Mean Difference (Random, 95% CI) -0.03 [-0.24, 0.18]
3 Retention in treatment 5 447 Std. Mean Difference (Random, 95% CI) 0.01 [-0.45, 0.47]
Analysis 1.1. Comparison 1 MI versus no intervention, Outcome 1 Extent of substance use.
Review: Motivational interviewing for substance abuse
Comparison: 1 MI versus no intervention
Outcome: 1 Extent of substance use
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Post-intervention
Ball 2007a 29 34 0.47 (0.26) 34.7 % 0.47 [ -0.04, 0.98 ]
Connors 2002 36 40 0.878 (0.241) 40.2 % 0.88 [ 0.41, 1.35 ]
Kelly 2000 16 16 1.245 (0.386) 15.9 % 1.25 [ 0.49, 2.00 ]
Stotts 2006 14 17 0.801 (0.507) 9.2 % 0.80 [ -0.19, 1.79 ]
Subtotal (95% CI) 100.0 % 0.79 [ 0.48, 1.09 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 3.04, df = 3 (P = 0.39); I2 =1%
Test for overall effect: Z = 5.10 (P < 0.00001)
2 Short f-u
Bell 2007 20 40 -0.028 (0.346) 1.4 % -0.03 [ -0.71, 0.65 ]
Carey 2006 81 81 0.19 (0.111) 9.8 % 0.19 [ -0.03, 0.41 ]
Carroll 2006a 178 173 0.097 (0.076) 15.4 % 0.10 [ -0.05, 0.25 ]
Feldstein 2007 15 40 0.345 (0.305) 1.8 % 0.35 [ -0.25, 0.94 ]
Kay-Lambkin 2009 30 35 -0.048 (0.25) 2.6 % -0.05 [ -0.54, 0.44 ]
Kelly 2000 16 16 1.23 (0.386) 1.2 % 1.23 [ 0.47, 1.99 ]
MarijuanaTP 2004 148 146 0.32 (0.118) 9.0 % 0.32 [ 0.09, 0.55 ]
-2 -1 0 1 2
Favours control Favours MI
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(. . . Continued)
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Martin 2008 20 20 -0.099 (0.317) 1.7 % -0.10 [ -0.72, 0.52 ]
Mastroleo 2010 82 82 0.276 (0.161) 5.6 % 0.28 [ -0.04, 0.59 ]
Morgenstern 2009 80 70 0.299 (0.162) 5.6 % 0.30 [ -0.02, 0.62 ]
Naar-King 2007 26 25 -0.041 (0.283) 2.1 % -0.04 [ -0.60, 0.51 ]
Peterson 2006 94 92 -0.004 (0.102) 11.0 % 0.00 [ -0.20, 0.20 ]
Schaus 2009 182 181 0.25 (0.11) 10.0 % 0.25 [ 0.03, 0.47 ]
Stein 2002 92 95 0.084 (0.103) 10.9 % 0.08 [ -0.12, 0.29 ]
Wood 2007 83 84 0.231 (0.095) 12.0 % 0.23 [ 0.04, 0.42 ]
Subtotal (95% CI) 100.0 % 0.17 [ 0.09, 0.26 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 18.40, df = 14 (P = 0.19); I2 =24%
Test for overall effect: Z = 4.08 (P = 0.000046)
3 Medium f-u
Brown 2010 92 92 0.042 (0.148) 9.8 % 0.04 [ -0.25, 0.33 ]
Carey 2006 81 81 -0.019 (0.157) 8.9 % -0.02 [ -0.33, 0.29 ]
Connors 2002 36 40 0.38 (0.232) 4.7 % 0.38 [ -0.07, 0.83 ]
Copeland 2001 69 78 0.525 (0.453) 1.3 % 0.53 [ -0.36, 1.41 ]
Emmen 2005 62 61 -0.2 (0.181) 7.1 % -0.20 [ -0.55, 0.15 ]
Freyer-Adam 2008 249 225 0.064 (0.109) 15.0 % 0.06 [ -0.15, 0.28 ]
Kay-Lambkin 2009 30 35 0.424 (0.252) 4.0 % 0.42 [ -0.07, 0.92 ]
Marsden 2006 176 166 0.099 (0.108) 15.1 % 0.10 [ -0.11, 0.31 ]
Morgenstern 2009 80 70 0.37 (0.172) 7.7 % 0.37 [ 0.03, 0.71 ]
Schaus 2009 182 181 0.2 (0.11) 14.8 % 0.20 [ -0.02, 0.42 ]
Stein 2009 92 95 0.173 (0.164) 8.3 % 0.17 [ -0.15, 0.49 ]
Winters 2007 27 26 0.657 (0.287) 3.2 % 0.66 [ 0.09, 1.22 ]
Subtotal (95% CI) 100.0 % 0.15 [ 0.04, 0.25 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 14.06, df = 11 (P = 0.23); I2 =22%
Test for overall effect: Z = 2.78 (P = 0.0055)
4 Long follow-up
Schaus 2009 182 181 0.06 (0.11) 100.0 % 0.06 [ -0.16, 0.28 ]
Subtotal (95% CI) 100.0 % 0.06 [ -0.16, 0.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.59)
-2 -1 0 1 2
Favours control Favours MI
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Analysis 1.2. Comparison 1 MI versus no intervention, Outcome 2 Readiness to change.
Review: Motivational interviewing for substance abuse
Comparison: 1 MI versus no intervention
Outcome: 2 Readiness to change
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Brown 2010 92 92 -0.22 (0.19) 13.9 % -0.22 [ -0.59, 0.15 ]
Carroll 2006a 178 173 0.18 (0.08) 32.2 % 0.18 [ 0.02, 0.34 ]
Emmen 2005 62 61 0.38 (0.22) 11.3 % 0.38 [ -0.05, 0.81 ]
Freyer-Adam 2008 249 225 -0.11 (0.18) 15.0 % -0.11 [ -0.46, 0.24 ]
Schaus 2009 182 181 0 (0.1) 27.7 % 0.0 [ -0.20, 0.20 ]
Total (95% CI) 100.0 % 0.05 [ -0.11, 0.22 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 7.67, df = 4 (P = 0.10); I2 =48%
Test for overall effect: Z = 0.63 (P = 0.53)
-2 -1 0 1 2
Favours control Favours MI
Analysis 1.3. Comparison 1 MI versus no intervention, Outcome 3 Retention in treatment.
Review: Motivational interviewing for substance abuse
Comparison: 1 MI versus no intervention
Outcome: 3 Retention in treatment
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Carroll 2006a 178 173 0.18 (0.08) 75.2 % 0.18 [ 0.02, 0.34 ]
Connors 2002 36 40 0.488 (0.233) 24.8 % 0.49 [ 0.03, 0.94 ]
Total (95% CI) 100.0 % 0.26 [ 0.00, 0.52 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 1.56, df = 1 (P = 0.21); I2 =36%
Test for overall effect: Z = 1.93 (P = 0.054)
-2 -1 0 1 2
Favours control Favours MI
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Analysis 2.1. Comparison 2 MI versus treatment as usual, Outcome 1 Extent of substance use.
Review: Motivational interviewing for substance abuse
Comparison: 2 MI versus treatment as usual
Outcome: 1 Extent of substance use
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Post-intervention
Ball 2007b 245 216 -0.172 (0.117) 20.1 % -0.17 [ -0.40, 0.06 ]
Carroll 2009 222 214 0 (0.096) 29.8 % 0.0 [ -0.19, 0.19 ]
D’Amico 2008 26 38 0.286 (0.311) 2.8 % 0.29 [ -0.32, 0.90 ]
Kavanagh 2004 12 13 0.539 (0.505) 1.1 % 0.54 [ -0.45, 1.53 ]
Maisto 2001 100 100 0.127 (0.16) 10.7 % 0.13 [ -0.19, 0.44 ]
Saitz 2007 169 172 0.047 (0.135) 15.1 % 0.05 [ -0.22, 0.31 ]
Walitzer 2008 58 58 0.092 (0.204) 6.6 % 0.09 [ -0.31, 0.49 ]
Walker 2006 50 47 0.078 (0.203) 6.7 % 0.08 [ -0.32, 0.48 ]
Winhusen 2008 98 102 -0.014 (0.197) 7.1 % -0.01 [ -0.40, 0.37 ]
Subtotal (95% CI) 100.0 % 0.01 [ -0.09, 0.11 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.21, df = 8 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
2 Short f-u
Ball 2007b 245 216 -0.137 (0.118) 13.9 % -0.14 [ -0.37, 0.09 ]
Bazargan-Hejazi 2005 151 144 0.165 (0.204) 4.6 % 0.17 [ -0.23, 0.56 ]
Carroll 2009 222 214 0 (0.096) 21.0 % 0.0 [ -0.19, 0.19 ]
D’Amico 2008 26 38 0.286 (0.311) 2.0 % 0.29 [ -0.32, 0.90 ]
Kavanagh 2004 12 13 0.43 (0.512) 0.7 % 0.43 [ -0.57, 1.43 ]
Maisto 2001 100 100 0.101 (0.16) 7.6 % 0.10 [ -0.21, 0.41 ]
Miller 2003 104 104 -0.028 (0.098) 20.1 % -0.03 [ -0.22, 0.16 ]
Walitzer 2008 58 58 0.214 (0.201) 4.8 % 0.21 [ -0.18, 0.61 ]
Walker 2006 50 47 0.078 (0.203) 4.7 % 0.08 [ -0.32, 0.48 ]
Winhusen 2008 98 102 -0.014 (0.097) 20.6 % -0.01 [ -0.20, 0.18 ]
Subtotal (95% CI) 100.0 % 0.01 [ -0.08, 0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.28, df = 9 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.24 (P = 0.81)
3 Medium f-u
-2 -1 0 1 2
Favours TAU Favours MI
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Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Kavanagh 2004 12 13 0.865 (0.484) 1.9 % 0.87 [ -0.08, 1.81 ]
Maisto 2001 100 100 0.152 (0.16) 17.3 % 0.15 [ -0.16, 0.47 ]
Miller 2003 104 104 0.071 (0.098) 46.1 % 0.07 [ -0.12, 0.26 ]
Saitz 2007 169 172 0.047 (0.135) 24.3 % 0.05 [ -0.22, 0.31 ]
Walitzer 2008 58 58 -0.03 (0.207) 10.3 % -0.03 [ -0.44, 0.38 ]
Subtotal (95% CI) 100.0 % 0.08 [ -0.05, 0.21 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.18, df = 4 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
-2 -1 0 1 2
Favours TAU Favours MI
Analysis 2.2. Comparison 2 MI versus treatment as usual, Outcome 2 Retention in treatment.
Review: Motivational interviewing for substance abuse
Comparison: 2 MI versus treatment as usual
Outcome: 2 Retention in treatment
Study or subgroup Control MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Ball 2007b 245 216 -0.1 (0.13) 34.2 % -0.10 [ -0.35, 0.15 ]
Carroll 2009 222 214 0.14 (0.1) 38.1 % 0.14 [ -0.06, 0.34 ]
Saitz 2007 169 172 -1.424 (0.811) 3.3 % -1.42 [ -3.01, 0.17 ]
Walitzer 2008 58 58 -0.35 (0.21) 24.4 % -0.35 [ -0.76, 0.06 ]
Total (95% CI) 100.0 % -0.11 [ -0.41, 0.19 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 8.39, df = 3 (P = 0.04); I2 =64%
Test for overall effect: Z = 0.74 (P = 0.46)
-4 -2 0 2 4
Favours treatment as usua Favours MI
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Analysis 3.1. Comparison 3 MI versus assessment and feedback, Outcome 1 Extent of substance use.
Review: Motivational interviewing for substance abuse
Comparison: 3 MI versus assessment and feedback
Outcome: 1 Extent of substance use
Study or subgroup Assessment and feedback MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Short f-u
Bernstein 2009 71 68 0.039 (0.288) 5.1 % 0.04 [ -0.53, 0.60 ]
Bien 1993 16 16 0.334 (0.253) 6.6 % 0.33 [ -0.16, 0.83 ]
Sellman 2001 40 42 0.229 (0.291) 5.0 % 0.23 [ -0.34, 0.80 ]
Stein 2010 120 125 0.227 (0.153) 18.0 % 0.23 [ -0.07, 0.53 ]
Stephens 2007 64 62 0.299 (0.181) 12.9 % 0.30 [ -0.06, 0.65 ]
Walters 2009 67 73 0.015 (0.12) 29.3 % 0.02 [ -0.22, 0.25 ]
White 2006 104 118 -0.008 (0.135) 23.1 % -0.01 [ -0.27, 0.26 ]
Subtotal (95% CI) 100.0 % 0.12 [ -0.01, 0.24 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 4.06, df = 6 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.071)
2 Medium f-u
Bernstein 2009 71 68 0.456 (0.229) 38.5 % 0.46 [ 0.01, 0.90 ]
Stephens 2007 64 62 0.333 (0.181) 61.5 % 0.33 [ -0.02, 0.69 ]
Subtotal (95% CI) 100.0 % 0.38 [ 0.10, 0.66 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 2.68 (P = 0.0074)
-2 -1 0 1 2
Favours assessm. % feedb. Favours MI
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Analysis 4.1. Comparison 4 MI versus other active intervention, Outcome 1 Extent of substance use.
Review: Motivational interviewing for substance abuse
Comparison: 4 MI versus other active intervention
Outcome: 1 Extent of substance use
Study or subgroup Other intervention MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Post-intervention
Anton 2005 41 39 -0.04 (0.233) 42.7 % -0.04 [ -0.50, 0.42 ]
Kadden 2007 50 55 -0.094 (0.201) 57.3 % -0.09 [ -0.49, 0.30 ]
Subtotal (95% CI) 100.0 % -0.07 [ -0.37, 0.23 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.47 (P = 0.64)
2 Short f-u
Barnett 2007 113 112 -0.049 (0.133) 12.4 % -0.05 [ -0.31, 0.21 ]
Borsari 2005 30 34 0.14 (0.251) 3.5 % 0.14 [ -0.35, 0.63 ]
Carroll 2006b 34 33 -0.114 (0.262) 3.2 % -0.11 [ -0.63, 0.40 ]
Chanut 2007 27 24 0.14 (0.24) 3.8 % 0.14 [ -0.33, 0.61 ]
De Wildt 2002 77 86 0.222 (0.195) 5.8 % 0.22 [ -0.16, 0.60 ]
Kadden 2007 50 55 -0.079 (0.202) 5.4 % -0.08 [ -0.47, 0.32 ]
Kahler 2004 24 24 0.012 (0.334) 2.0 % 0.01 [ -0.64, 0.67 ]
Martino 2006 20 24 0.189 (0.341) 1.9 % 0.19 [ -0.48, 0.86 ]
McCambridge 2008 162 164 0.078 (0.119) 15.5 % 0.08 [ -0.16, 0.31 ]
UKATT 2005 320 442 0.014 (0.08) 34.3 % 0.01 [ -0.14, 0.17 ]
Walitzer 2008 53 58 -0.271 (0.202) 5.4 % -0.27 [ -0.67, 0.12 ]
Wood 2007 87 84 0.127 (0.178) 6.9 % 0.13 [ -0.22, 0.48 ]
Subtotal (95% CI) 100.0 % 0.02 [ -0.07, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.24, df = 11 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
3 Medium f-u
Barnett 2007 113 112 0.019 (0.133) 18.0 % 0.02 [ -0.24, 0.28 ]
Chanut 2007 27 24 0.41 (0.2) 10.4 % 0.41 [ 0.02, 0.80 ]
Kadden 2007 50 55 -0.005 (0.202) 10.2 % -0.01 [ -0.40, 0.39 ]
MATCH 1993 164 168 -0.116 (0.097) 24.7 % -0.12 [ -0.31, 0.07 ]
UKATT 2005 320 442 0.01 (0.087) 26.9 % 0.01 [ -0.16, 0.18 ]
-1 -0.5 0 0.5 1
Favours other active Favours MI
(Continued . . . )
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(. . . Continued)
Study or subgroup Other intervention MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Walitzer 2008 53 58 -0.364 (0.208) 9.8 % -0.36 [ -0.77, 0.04 ]
Subtotal (95% CI) 100.0 % -0.02 [ -0.16, 0.13 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 8.55, df = 5 (P = 0.13); I2 =41%
Test for overall effect: Z = 0.22 (P = 0.83)
4 Long f-u
Kadden 2007 50 55 0.063 (0.206) 18.1 % 0.06 [ -0.34, 0.47 ]
MATCH 1993 164 168 -0.055 (0.097) 81.9 % -0.06 [ -0.25, 0.14 ]
Subtotal (95% CI) 100.0 % -0.03 [ -0.21, 0.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.27, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
-1 -0.5 0 0.5 1
Favours other active Favours MI
Analysis 4.2. Comparison 4 MI versus other active intervention, Outcome 2 Readiness to change.
Review: Motivational interviewing for substance abuse
Comparison: 4 MI versus other active intervention
Outcome: 2 Readiness to change
Study or subgroup Other intervention MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Barnett 2007 113 112 -0.02 (0.13) 69.2 % -0.02 [ -0.27, 0.23 ]
Kadden 2007 62 63 -0.051 (0.195) 30.8 % -0.05 [ -0.43, 0.33 ]
Total (95% CI) 100.0 % -0.03 [ -0.24, 0.18 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.27 (P = 0.78)
-2 -1 0 1 2
Favours other active Favours MI
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Analysis 4.3. Comparison 4 MI versus other active intervention, Outcome 3 Retention in treatment.
Review: Motivational interviewing for substance abuse
Comparison: 4 MI versus other active intervention
Outcome: 3 Retention in treatment
Study or subgroup Other intervention MI Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Anton 2005 41 39 -0.79 (0.72) 7.9 % -0.79 [ -2.20, 0.62 ]
De Wildt 2002 78 86 0.06 (0.17) 26.2 % 0.06 [ -0.27, 0.39 ]
Kahler 2004 24 24 -0.3 (0.31) 19.9 % -0.30 [ -0.91, 0.31 ]
Martino 2006 20 24 0.87 (0.27) 21.7 % 0.87 [ 0.34, 1.40 ]
Walitzer 2008 53 58 -0.31 (0.21) 24.4 % -0.31 [ -0.72, 0.10 ]
Total (95% CI) 100.0 % 0.01 [ -0.45, 0.47 ]
Heterogeneity: Tau2 = 0.18; Chi2 = 14.76, df = 4 (P = 0.01); I2 =73%
Test for overall effect: Z = 0.03 (P = 0.98)
-4 -2 0 2 4
Favours other active Favours MI
A P P E N D I C E S
Appendix 1. Ovid MEDLINE
1950 to November Week 3 2010
Date: 30.11.2010
1 Interview, Psychological/
2 Feedback, Psychological/
3 (interview$ or feedback$ or enhancement).tw.
4 or/1-3
5 Motivation/
6 motivational$.tw.
7 or/5-6
8 4 and 7
9 exp Substance-Related Disorders/
10 ((drug or substance$ or alcohol or opioid$ or amphetamine$ or cocaine or marijuana or cannabis or phencyclidine or benzodiaz$)
adj2 (misuse or abuse$ or addict$ or depend$)).tw.
11 (alcoholi$ or drinker$ or drinking$).tw.
12 exp benzodiazepines/
13 or/9-12
14 8 and 13
15 clinical trial.pt.
16 randomized controlled trial.pt.
17 controlled clinical trial.pt.
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18 randomized.ti,ab.
19 placebo.ti,ab.
20 dt.fs.
21 randomly.ti,ab.
22 trial.ti,ab.
23 groups.ti,ab.
24 control$.ti,ab.
25 quasi$.ti,ab.
26 cluster$.ti,ab.
27 or/15-26
28 Animals/
29 Humans/
30 28 not (28 and 29)
31 27 not 30
32 31 and 14
Appendix 2. Ovid EMBASE
1980 to 2010 Week 46
Date: 30.11.2010
1. exp interview/
2. (interview$ or feedback$ or enhancement).tw.
3. or/1-2
4. motivation/
5. Motivational$.tw.
6. or/4-5
7. Substance Abuse/
8. exp drug abuse/
9. exp Alcohol Abuse/
10. exp Drug Dependence/
11. Alcoholism/
12. Addiction/
13. Withdrawal Syndrome/
14. ((drug or substance$ or alcohol or opioid$ or amphetamine$ or cocaine or marijuana or cannabis or phencyclidine or benzodiaz$)
adj2 (misuse or abuse$ or addict$ or depend$)).tw.
15. (alcoholi$ or drinker$ or drinking$).tw.
16. or/7-15
17. 3 and 6 and 16
18. Clinical Trial/
19. Randomized Controlled Trial/
20. Randomization/
21. Double Blind Procedure/
22. Single Blind Procedure/
23. Crossover Procedure/
24. PLACEBO/
25. placebo$.tw.
26. randomi?ed controlled trial$.tw.
27. rct.tw.
28. random allocation.tw.
29. randomly allocated.tw.
30. allocated randomly.tw.
31. (allocated adj2 random).tw.
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32. single blind$.tw.
33. double blind$.tw.
34. ((treble or triple) adj blind$).tw.
35. Prospective study/
36. or/18-35
37. Case study/
38. case report.tw.
39. Abstract report/
40. Letter/
41. Human/
42. Nonhuman/
43. ANIMAL/
44. Animal Experiment/
45. 42 or 43 or 44
46. 45 not (41 and 45)
47. or/37-40,46
48. 36 not 47
49. control$.ti,ab.
50. quasi$.ti,ab.
51. cluster$.ti,ab.
52. or/49-51
53. 36 or 52
54. 53 not 47
55. 54 and 17
Appendix 3. Ovid PsycINFO
Date: 30.11.2010
1806 to November Week 4 2010
1 exp motivational interviewing/
2 (interview$ or feedback$ or enhancement$).tw.
3 Motivational$.tw.
4 2 and 3
5 1 or 4
6 exp drug abuse/
7 exp addiction/
8 ((drug or substance$ or alcohol or opioid$ or amphetamine$ or cocaine or marijuana or cannabis or phencyclidine or benzodiaz$)
adj2 (misuse or abuse$ or addict$ or depend$)).tw.
9 (alcoholi$ or drinker$ or drinking$).tw.
10 or/6-9
11 methodology/
12 data collection/
13 empirical methods/
14 Experimental methods/
15 Quasi experimental methods/
16 experimental design/
17 between groups design/
18 followup studies/
19 exp longitudinal studies/
20 repeated measures/
21 experimental subjects/
22 experiment controls/
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23 experimental replication/
24 exp “sampling (experimental)”/
25 placebo/
26 clinical trials/
27 exp treatment outcomes/
28 treatment effectiveness evaluation/
29 empirical study.md.
30 experimental replication.md.
31 followup study.md.
32 longitudinal study.md.
33 meta analysis.md.
34 prospective study.md.
35 retrospective study.md.
36 treatment outcome clinical trial.md.
37 placebo$.tw.
38 randomi?ed controlled trial$.tw.
39 rct.tw.
40 random allocation.tw.
41 (randomly adj1 allocated).tw.
42 (allocated adj2 random).tw.
43 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw.
44 (clinic$ adj (trial? or stud$3)).tw.
45 or/11-44
46 comment reply.dt.
47 editorial.dt.
48 letter.dt.
49 clinical case study.md.
50 nonclinical case study.md.
51 animal.po.
52 human.po.
53 51 not (51 and 52)
54 or/46-50,53
55 45 not 54
56 control$.ti,ab.
57 quasi$.ti,ab.
58 cluster$.ti,ab.
59 or/56-58
60 45 or 59
61 60 not 54
62 5 and 10 and 61
Appendix 4. Wiley; Cochrane Library
Clinical Trials
Date: 30.11.2010
#1 MeSH descriptor Interview, Psychological explode all trees
#2 MeSH descriptor Feedback, Psychological explode all trees
#3 (interview* or feedback* or enhancement):ab,ti
#4 (#1 OR #2 OR #3)
#5 MeSH descriptor Motivation explode all trees
#6 motivational*:ti,ab
#7 (#5 OR #6)
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#8 (#4 AND #7)
#9 MeSH descriptor Substance-Related Disorders explode all trees
#10 MeSH descriptor Benzodiazepines explode all trees
#11 ((drug or substance* or alcohol or opioid* or amphetamine* or cocaine or marijuana or cannabis or phencyclidine or benzodiaz*)
near/2 (misuse or abuse* or addict* or depend*)):ti,ab
#12 (alcoholi* or drinker* or drinking*):ti,ab
#13 (#9 OR #10 OR #11 OR #12)
Appendix 5. Ovid PsychExtra
1908 to January 14, 2008
Date: 21.01.2008
Note: RCT-filter not used
1 exp CRIMINALS/
2 exp CRIME/
3 exp Correctional Institutions/
4 exp PRISONERS/
5 (prison$ or imprison$ or offender$ or offence$ or incarcerat$ or crim$ or jail$ or delinq$ or punish$ or convict$ or penitentiar$
or correctional or penal or inmate$ or captive$).tw.
6 or/1-5
7 Motivational Interviewing/
8 (interview$ or feedback$ or enhancement therap$).tw.
9 Motivational$.tw.
10 8 and 9
11 7 or 10
12 exp drug abuse/
13 exp addiction/
14 ((drug or substance$ or alcohol or opioid$ or amphetamine$ or cocaine or marijuana or cannabis or phencyclidine or benzodiaz$)
adj2 (misuse or abuse$ or addict$ or depend$)).tw.
15 or/12-14
16 6 and 11 and 15
17 11 and 15
Appendix 6. International Bibliography of the Social Sciences
1951 to November Week 3 2009
Note: RCT-filter not used
1 exp motivation/
2 motivational*.tw.
3 or/1-2
4 exp interviews/
5 (interview* or feedback* or enhancement).tw.
6 or/4-5
7 3 and 6
8 exp drug addiction/ or exp drug addicts/
9 exp “drug use”/
10 exp drug users/
11 ((drug or substance* or alcohol or opioid* or amphetamine* or cocaine or marijuana or cannabis or phencyclidine or benzodiaz*)
adj2 (misuse or abuse* or addict* or depend*)).tw.
12 exp cannabis/
13 exp drugs/
14 exp alcohol/
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15 exp alcoholism/
16 addiction/ or addicts/
17 exp “substance use”/
18 (alcoholi* or drinker* or drinking*).tw.
19 or/8-18
20 7 and 19
Appendix 7. ISI Web of Science (Thomson)
Date: 30.11.2010
Note: RCT-filter not used
# 7 #6 AND #3
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 6 #5 AND #4
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 5 Topic=(motivational*)
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 4 Topic=(interview* or feedback* or enhancement)
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 3 #2 OR #1
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 2 Topic=(alcoholi* or drinker* or drinking*)
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
# 1 Topic=((((drug or substance* or alcohol or opioid* or amphetamine* or cocaine or marijuana or cannabis or phencyclidine or
benzodiaz*) same (misuse or abuse* or addict* or depend*))))
Databases=SCI-EXPANDED, SSCI, A&HCI Timespan=All Years
Appendix 8. C2-SPECTR
Date: 23.11.2009
Note: RCT-filter not used
interview or enhancement or feedback AND (motivational or motivation)
Appendix 9. Sociological Abstracts
CSA Illumina
Date: 30.11.2010
Note: RCT-filter not used
(((drug or substance* or alcohol or opioid* or amphetamine* or cocaine or marijuana or cannabis or phencyclidine or benzodiaz*)
within 2 (misuse or abuse* or addict* or depend*)) or (alcoholi* or drinker* or drinking*) or (DE=(“addiction” or “drug addiction”
or “drug injection” or “drugs” or “narcotic drugs” or “opiates” or “heroin” or “psychedelic drugs” or “lysergic acid diethylamide” or
“tranquilizing drugs”)) or (DE=(“substance abuse” or “alcohol abuse” or “drug abuse” or “drug addiction”))) and (((interview* or
feedback* or enhancement) or (DE=“feedback”) or (DE=“interviews”)) and ((motivational*) or (DE=“motivation”)))
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Appendix 10. SveMed+
Date: 30.11.2010
Note: RCT-filter not used
Search term: motivational
Appendix 11. Bibliograpy of Nordic Criminology
Date: 23.11.2009
Note: RCT-filter not used
Search term: motivational
Appendix 12. CINCH
Date: 30.11.2010
Note: RCT-filter not used
Search term: +motivational
Appendix 13. NCJRS
Date: 30.11.2010
Note: RCT-filter not used
Search term:
Subject: motivational (Site search)
Appendix 14. Springerlink
Date: 02.10.2010
Note: RCT-filter not used
Search terms:
Summary: motivational and (interview* or feedback* or enhancement*)
Appendix 15. Wiley Interscience
Date: 02.12.2010
Note: RCT-filter not used
Search terms:
motivational and (interview* or feedback* or enhancement*) in Article Titles
Appendix 16. Drug Data (formerly DrugScope Library)
Date: 02.12.2010
Note: RCT-filter not used
Search terms:
Title or Subject: motivational interview* or motivational feedback* or motivational enhancement*
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Appendix 17. Electronic Library of the National Documentation Centre on DRug Use (NCD)
Date: 02.12.2010
Note: RCT-filter not used
Search term:
Motivational
Appendix 18. Google
Date: 02.02.2009
research OR evaluation OR evaluations OR outcome OR outcomes OR effect OR effects OR trial OR trials OR study OR studies
“motivational interviewing”
First 100 hits
Appendix 19. Google Scholar
Date: 02.02.2009
research OR evaluation OR evaluations OR outcome OR outcomes OR effect OR effects OR trial OR trials OR study OR studies
“motivational interviewing”
First 100 hits
Appendix 20. Drug Data
Date 02.12.2010
H I S T O R Y
Protocol first published: Issue 4, 2009
Review first published: Issue 5, 2011
Date Event Description
13 January 2011 Amended First draft of this review.
C O N T R I B U T I O N S O F A U T H O R S
Karlsen conceived of the idea and commissioned the review. All reviewers were involved in planning the review. Smedslund wrote
the methods section of the protocol. Karlsen and Smedslund wrote the background. Hammerstrøm developed the search strategy,
performed the original searches and the final search in November 2010. All authors were involved with screening of studies. Smedslund
and Berg did the risk of bias and data extraction. Berg and Smedslund graded the results. Smedslund did the analyses and wrote the
results and discussion.
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D E C L A R A T I O N S O F I N T E R E S T
None.
S O U R C E S O F S U P P O R T
Internal sources
• Norwegian Knowledge Centre for the Health Services, Norway.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We excluded studies that recruited participants in emergency rooms and provided one session of MI during the stay in the emergency
room. Some of the searches in electronic databases are not up to date. PsychExtra (search date January 14, 2008) and International
Bibliography of the Social Sciences (November 2009) were not searched inNovember 2010 because we did not have access. C2 SPECTR
and Bibliography of Nordic Criminology were searched on November 23, 2009, and these databases have not been updated since this
date. Google and Google Scholar were searched on February 2, 2009, and we did not believe that a new search was worthwhile in
November 2010.
In cases where effect size information could not be obtained from the authors of the primary studies, we used effect size data from
published systematic reviews and meta-analyses. If necessary, we contacted the authors of the systematic reviews/meta-analyses for more
information.
We do not report fixed-effect meta-analyses because we believe that there are systematic differences between studies related to differences
in interventions given, populations studied, comparison groups, and outcome measures.
We did not do separate analyses for persons with and without mental problems. There was only one study (Martino 2006), in which the
participants were explicitly described as having mental problems, but mental problems are so frequently co-occurring with substance
abuse that we did not believe it was meaningful to do separate analyses for this variable.
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